BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1332765 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H23FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-11,13,16,30H,12,14-15H2,1H3,(H,29,31,33) YQCOGLQBRIXLTH-UHFFFAOYSA-N 625175 US20230322767, Example 1::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform alpha Homo sapiens 1.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625175&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687101 485207538 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332766 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H23FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-11,13,16,30H,12,14-15H2,1H3,(H,29,31,33) YQCOGLQBRIXLTH-UHFFFAOYSA-N 625175 US20230322767, Example 1::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform delta Homo sapiens 3.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625175&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687101 485207538 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332767 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform alpha Homo sapiens 1.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332768 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform delta Homo sapiens 3.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332769 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform alpha Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332770 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform delta Homo sapiens 5.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332771 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform alpha Homo sapiens 1.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332772 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Casein kinase I isoform delta Homo sapiens 2.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332773 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H21FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-14,16,30H,15H2,1H3,(H,29,31,33) FHPAOPMOHMSKCE-UHFFFAOYSA-N 625179 US20230322767, Example 5::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform alpha Homo sapiens 0.860 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625179&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687228 485207540 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332774 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H21FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-14,16,30H,15H2,1H3,(H,29,31,33) FHPAOPMOHMSKCE-UHFFFAOYSA-N 625179 US20230322767, Example 5::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform delta Homo sapiens 2.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625179&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687228 485207540 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332775 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform alpha Homo sapiens 2.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332776 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform delta Homo sapiens 3.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332777 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform alpha Homo sapiens 7.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332778 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform delta Homo sapiens 7.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332779 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform alpha Homo sapiens 0.940 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332780 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Casein kinase I isoform delta Homo sapiens 2.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332781 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform alpha Homo sapiens 7.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332782 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform delta Homo sapiens 9.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332783 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform alpha Homo sapiens 110 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332784 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform delta Homo sapiens 64.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332785 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform alpha Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332786 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Casein kinase I isoform delta Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332787 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H22FN5O2/c1-32-12-9-20-24(26(32)34)23(18-3-2-10-28-15-18)25(30-20)17-8-11-29-21(14-17)31-22(33)13-16-4-6-19(27)7-5-16/h2-8,10-11,14-15,30H,9,12-13H2,1H3,(H,29,31,33) LOTGQVOARVITHH-UHFFFAOYSA-N 625186 US20230322767, Example 12::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform alpha Homo sapiens 10.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625186&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687126 485207543 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332788 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H22FN5O2/c1-32-12-9-20-24(26(32)34)23(18-3-2-10-28-15-18)25(30-20)17-8-11-29-21(14-17)31-22(33)13-16-4-6-19(27)7-5-16/h2-8,10-11,14-15,30H,9,12-13H2,1H3,(H,29,31,33) LOTGQVOARVITHH-UHFFFAOYSA-N 625186 US20230322767, Example 12::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform delta Homo sapiens 13.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625186&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687126 485207543 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332789 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H26F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,17,21,37H,15-16H2,1-2H3,(H,35,36,39) TVWCCJYWNNRHHQ-UHFFFAOYSA-N 625187 US20230322767, Example 13::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 3.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625187&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686998 485207544 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332790 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H26F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,17,21,37H,15-16H2,1-2H3,(H,35,36,39) TVWCCJYWNNRHHQ-UHFFFAOYSA-N 625187 US20230322767, Example 13::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 3.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625187&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686998 485207544 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332791 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625188 US20230322767, Example 14::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625188&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207545 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332792 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625188 US20230322767, Example 14::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625188&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207545 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332793 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625189 US20230322767, Example 15::(+)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 2.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625189&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207546 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332794 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625189 US20230322767, Example 15::(+)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 2.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625189&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207546 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332795 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625190 US20230322767, Example 16::(-)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 7.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625190&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207547 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332796 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625190 US20230322767, Example 16::(-)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625190&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207547 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332797 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,20,22-23,40H,14-16H2,1H3,(H,38,39,42) ZIJTUQQBFTXSRP-UHFFFAOYSA-N 625191 US20230322767, Example 17::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625191&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687110 485207548 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332798 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,20,22-23,40H,14-16H2,1H3,(H,38,39,42) ZIJTUQQBFTXSRP-UHFFFAOYSA-N 625191 US20230322767, Example 17::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625191&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687110 485207548 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332799 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625192 US20230322767, Example 18::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625192&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207549 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332800 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625192 US20230322767, Example 18::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625192&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207549 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332801 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625193 US20230322767, Example 19::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 22.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625193&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207550 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332802 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625193 US20230322767, Example 19::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625193&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207550 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332803 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625194 US20230322767, Example 20::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625194&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207551 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332804 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625194 US20230322767, Example 20::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625194&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207551 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332805 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H25F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,16,20,38H,14-15H2,1-2H3,(H,36,37,40) CVDSGACKMHURND-UHFFFAOYSA-N 625195 US20230322767, Example 21::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 8.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625195&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687163 485207552 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332806 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H25F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,16,20,38H,14-15H2,1-2H3,(H,36,37,40) CVDSGACKMHURND-UHFFFAOYSA-N 625195 US20230322767, Example 21::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 6.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625195&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687163 485207552 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332807 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625196 US20230322767, Example 22::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 6.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625196&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207553 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332808 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625196 US20230322767, Example 22::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625196&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207553 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332809 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625197 US20230322767, Example 23::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 85.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625197&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207554 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332810 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625197 US20230322767, Example 23::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 37.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625197&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207554 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332811 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625198 US20230322767, Example 24::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625198&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207555 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332812 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625198 US20230322767, Example 24::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625198&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207555 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332813 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,19,22-23,41H,13-15H2,1H3,(H,39,40,43) YXAZIXFVTZLQCR-UHFFFAOYSA-N 625199 US20230322767, Example 25::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 6.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625199&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687193 485207556 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332814 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,19,22-23,41H,13-15H2,1H3,(H,39,40,43) YXAZIXFVTZLQCR-UHFFFAOYSA-N 625199 US20230322767, Example 25::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 5.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625199&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687193 485207556 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332815 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform alpha Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332816 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform delta Homo sapiens 7.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332817 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332818 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform delta Homo sapiens 5.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332819 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform alpha Homo sapiens 6.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332820 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Casein kinase I isoform delta Homo sapiens 5.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332821 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-14,16-17,34H,15H2,1-3H3,(H,32,33,36) JWORVNRMUHEHQU-UHFFFAOYSA-N 625203 US20230322767, Example 29::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 2.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625203&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687095 485207558 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332822 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-14,16-17,34H,15H2,1-3H3,(H,32,33,36) JWORVNRMUHEHQU-UHFFFAOYSA-N 625203 US20230322767, Example 29::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625203&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687095 485207558 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332823 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625204 US20230322767, Example 30::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625204&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207559 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332824 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625204 US20230322767, Example 30::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625204&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207559 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332825 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625205 US20230322767, Example 31::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 53.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625205&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207560 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332826 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625205 US20230322767, Example 31::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625205&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207560 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332827 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625206 US20230322767, Example 32::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625206&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207561 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332828 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625206 US20230322767, Example 32::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 3.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625206&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207561 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332829 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H26F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,16,22-23,37H,14-15H2,1-2H3,(H,35,36,39) AFYHNCHUOWUSBR-UHFFFAOYSA-N 625207 US20230322767, Example 33::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625207&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687146 485207562 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332830 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H26F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,16,22-23,37H,14-15H2,1-2H3,(H,35,36,39) AFYHNCHUOWUSBR-UHFFFAOYSA-N 625207 US20230322767, Example 33::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625207&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687146 485207562 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332831 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625208 US20230322767, Example 34::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625208&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207563 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332832 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625208 US20230322767, Example 34::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 5.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625208&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207563 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332833 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625209 US20230322767, Example 35::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 66.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625209&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207564 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332834 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625209 US20230322767, Example 35::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 22.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625209&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207564 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332835 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625210 US20230322767, Example 36::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 3.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625210&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207565 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332836 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625210 US20230322767, Example 36::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 3.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625210&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207565 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332837 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-15,17-18,33H,16H2,1-3H3,(H,31,32,35) XXHPLAIMNDHJPS-UHFFFAOYSA-N 625211 US20230322767, Example 37::N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625211&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687083 485207566 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332838 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-15,17-18,33H,16H2,1-3H3,(H,31,32,35) XXHPLAIMNDHJPS-UHFFFAOYSA-N 625211 US20230322767, Example 37::N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625211&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687083 485207566 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332839 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H25FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-16,18,33H,1-3H3,(H,31,32,35) CUSGCSBOGPVLNM-UHFFFAOYSA-N 625212 US20230322767, Example 38::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 7.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625212&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687030 485207567 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332840 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H25FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-16,18,33H,1-3H3,(H,31,32,35) CUSGCSBOGPVLNM-UHFFFAOYSA-N 625212 US20230322767, Example 38::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 7.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625212&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687030 485207567 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332841 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Casein kinase I isoform alpha Homo sapiens 3.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332842 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Casein kinase I isoform delta Homo sapiens 3.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332843 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccccc1 InChI=1S/C30H25F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,16,22-23,36H,15H2,1-2H3,(H,34,35,38) ATJMVWABXWLODR-UHFFFAOYSA-N 625214 US20230322767, Example 40::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625214&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687246 485207569 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332844 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccccc1 InChI=1S/C30H25F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,16,22-23,36H,15H2,1-2H3,(H,34,35,38) ATJMVWABXWLODR-UHFFFAOYSA-N 625214 US20230322767, Example 40::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625214&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687246 485207569 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332845 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Casein kinase I isoform alpha Homo sapiens 5.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332846 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Casein kinase I isoform delta Homo sapiens 6.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332847 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-31-27(35)24-23(18-6-4-3-5-7-18)25(33-26(24)28)19-12-13-30-21(15-19)32-22(34)14-17-8-10-20(29)11-9-17/h3-13,15,33H,14,16H2,1-2H3,(H,31,35)(H,30,32,34) DZHGIWMUVYYVFJ-UHFFFAOYSA-N 625216 US20230322767, Example 42::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 1.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625216&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687118 485207570 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332848 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-31-27(35)24-23(18-6-4-3-5-7-18)25(33-26(24)28)19-12-13-30-21(15-19)32-22(34)14-17-8-10-20(29)11-9-17/h3-13,15,33H,14,16H2,1-2H3,(H,31,35)(H,30,32,34) DZHGIWMUVYYVFJ-UHFFFAOYSA-N 625216 US20230322767, Example 42::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 2.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625216&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687118 485207570 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332849 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform alpha Homo sapiens 2.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332850 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform delta Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332851 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform alpha Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332852 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform delta Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332853 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332854 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Casein kinase I isoform delta Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332855 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform alpha Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332856 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform delta Homo sapiens 3.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332857 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform alpha Homo sapiens 13.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332858 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform delta Homo sapiens 9.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332859 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform alpha Homo sapiens 1.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332860 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Casein kinase I isoform delta Homo sapiens 2.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332861 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625223 US20230322767, Example 49::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625223&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207573 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332862 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625223 US20230322767, Example 49::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625223&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207573 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332863 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625224 US20230322767, Example 50::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625224&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207574 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332864 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625224 US20230322767, Example 50::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 9.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625224&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207574 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332865 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625225 US20230322767, Example 51::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 1.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625225&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207575 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332866 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625225 US20230322767, Example 51::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 2.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625225&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207575 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332867 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625226 US20230322767, Example 52::2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 3.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625226&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207576 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332868 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625226 US20230322767, Example 52::2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625226&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207576 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332869 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625227 US20230322767, Example 53::(-)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 21.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625227&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207577 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332870 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625227 US20230322767, Example 53::(-)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 16.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625227&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207577 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332871 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625228 US20230322767, Example 54::(+)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 1.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625228&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207578 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332872 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625228 US20230322767, Example 54::(+)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 3.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625228&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207578 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332873 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H29FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17,19,23,35H,7-8,15-16,18H2,1H3,(H,33,34,37) IYIPKVLXGPQOAG-UHFFFAOYSA-N 625229 US20230322767, Example 55::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625229&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687184 485207579 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332874 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H29FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17,19,23,35H,7-8,15-16,18H2,1H3,(H,33,34,37) IYIPKVLXGPQOAG-UHFFFAOYSA-N 625229 US20230322767, Example 55::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Casein kinase I isoform delta Homo sapiens 2.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625229&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687184 485207579 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332875 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H27FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17-19,35H,7-8,15-16H2,1H3,(H,33,34,37) HINDFIKMXAKSSM-UHFFFAOYSA-N 625230 US20230322767, Example 56::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625230&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687047 485207580 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332876 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H27FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17-19,35H,7-8,15-16H2,1H3,(H,33,34,37) HINDFIKMXAKSSM-UHFFFAOYSA-N 625230 US20230322767, Example 56::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625230&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687047 485207580 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332877 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H31FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17,19-20,24,36H,8-9,16,18H2,1-2H3,(H,34,35,38) UJTVNGWILMVGHV-UHFFFAOYSA-N 625231 US20230322767, Example 57::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625231&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687204 485207581 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332878 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H31FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17,19-20,24,36H,8-9,16,18H2,1-2H3,(H,34,35,38) UJTVNGWILMVGHV-UHFFFAOYSA-N 625231 US20230322767, Example 57::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 2.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625231&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687204 485207581 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332879 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H29FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17-20,36H,8-9,16H2,1-2H3,(H,34,35,38) WOJAWRJOQHZDRX-UHFFFAOYSA-N 625232 US20230322767, Example 58::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625232&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687160 485207582 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332880 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H29FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17-20,36H,8-9,16H2,1-2H3,(H,34,35,38) WOJAWRJOQHZDRX-UHFFFAOYSA-N 625232 US20230322767, Example 58::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625232&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687160 485207582 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332881 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H31F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,19,23,25-26,39H,7-8,15,17-18H2,1H3,(H,37,38,41) CTPZTYYKWXJYMT-UHFFFAOYSA-N 625233 US20230322767, Example 59::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 4.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625233&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687043 485207583 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332882 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H31F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,19,23,25-26,39H,7-8,15,17-18H2,1H3,(H,37,38,41) CTPZTYYKWXJYMT-UHFFFAOYSA-N 625233 US20230322767, Example 59::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 3.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625233&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687043 485207583 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332883 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H29F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,18-19,25-26,39H,7-8,15,17H2,1H3,(H,37,38,41) ATBIVHXUOKHWSC-UHFFFAOYSA-N 625234 US20230322767, Example 60::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 15.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625234&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687076 485207584 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332884 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H29F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,18-19,25-26,39H,7-8,15,17H2,1H3,(H,37,38,41) ATBIVHXUOKHWSC-UHFFFAOYSA-N 625234 US20230322767, Example 60::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 9.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625234&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687076 485207584 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332885 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H28F2N4O2/c1-37-17-22(14-18-2-3-18)30-28(31(37)39)27(20-6-10-24(33)11-7-20)29(36-30)21-12-13-34-25(16-21)35-26(38)15-19-4-8-23(32)9-5-19/h4-13,16,18,22,36H,2-3,14-15,17H2,1H3,(H,34,35,38) KLWJMSQFXDPWNW-UHFFFAOYSA-N 625235 US20230322767, Example 61::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625235&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687084 485207585 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332886 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H28F2N4O2/c1-37-17-22(14-18-2-3-18)30-28(31(37)39)27(20-6-10-24(33)11-7-20)29(36-30)21-12-13-34-25(16-21)35-26(38)15-19-4-8-23(32)9-5-19/h4-13,16,18,22,36H,2-3,14-15,17H2,1H3,(H,34,35,38) KLWJMSQFXDPWNW-UHFFFAOYSA-N 625235 US20230322767, Example 61::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Casein kinase I isoform delta Homo sapiens 1.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625235&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687084 485207585 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332887 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H30F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16,18-19,23,37H,3-4,15,17H2,1-2H3,(H,35,36,39) QNOANZOPMMGGQK-UHFFFAOYSA-N 625236 US20230322767, Example 62::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 7.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625236&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687082 485207586 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332888 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H30F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16,18-19,23,37H,3-4,15,17H2,1-2H3,(H,35,36,39) QNOANZOPMMGGQK-UHFFFAOYSA-N 625236 US20230322767, Example 62::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625236&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687082 485207586 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332889 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H28F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16-19,37H,3-4,15H2,1-2H3,(H,35,36,39) GDPJYLRERIWTKI-UHFFFAOYSA-N 625237 US20230322767, Example 63::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625237&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686973 485207587 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332890 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H28F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16-19,37H,3-4,15H2,1-2H3,(H,35,36,39) GDPJYLRERIWTKI-UHFFFAOYSA-N 625237 US20230322767, Example 63::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 8.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625237&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686973 485207587 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332891 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H30F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,18,22,25-26,40H,2-3,14,16-17H2,1H3,(H,38,39,42) BUTAQMUMZATNRF-UHFFFAOYSA-N 625238 US20230322767, Example 64::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Casein kinase I isoform alpha Homo sapiens 8.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625238&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687128 485207588 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332892 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H30F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,18,22,25-26,40H,2-3,14,16-17H2,1H3,(H,38,39,42) BUTAQMUMZATNRF-UHFFFAOYSA-N 625238 US20230322767, Example 64::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Casein kinase I isoform delta Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625238&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687128 485207588 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332893 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H28F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,17-18,25-26,40H,2-3,14,16H2,1H3,(H,38,39,42) YWWLWBUGJCBTOP-UHFFFAOYSA-N 625239 US20230322767, Example 65::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625239&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687092 485207589 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332894 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H28F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,17-18,25-26,40H,2-3,14,16H2,1H3,(H,38,39,42) YWWLWBUGJCBTOP-UHFFFAOYSA-N 625239 US20230322767, Example 65::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 6.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625239&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687092 485207589 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332895 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform alpha Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332896 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform delta Homo sapiens 3.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332897 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform alpha Homo sapiens 16.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332898 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform delta Homo sapiens 8.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332899 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform alpha Homo sapiens 4.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332900 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Casein kinase I isoform delta Homo sapiens 5.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332901 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform alpha Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332902 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform delta Homo sapiens 2.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332903 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform alpha Homo sapiens 16.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332904 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform delta Homo sapiens 7.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332905 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform alpha Homo sapiens 1.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332906 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Casein kinase I isoform delta Homo sapiens 2.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332907 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCNC(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H21FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-10,12,15,30H,11,13-14H2,(H,29,33)(H,28,31,32) SFMADGWHRCGBSQ-UHFFFAOYSA-N 625246 US20230322767, Example 72::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform alpha Homo sapiens 0.660 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625246&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687104 485207592 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332908 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCNC(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H21FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-10,12,15,30H,11,13-14H2,(H,29,33)(H,28,31,32) SFMADGWHRCGBSQ-UHFFFAOYSA-N 625246 US20230322767, Example 72::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform delta Homo sapiens 1.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625246&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687104 485207592 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332909 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3cc[nH]c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H19FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-13,15,30H,14H2,(H,29,33)(H,28,31,32) RTZRQMLMSQRVKR-UHFFFAOYSA-N 625247 US20230322767, Example 73::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform alpha Homo sapiens 1.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625247&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 169422882 485207593 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332910 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3cc[nH]c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H19FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-13,15,30H,14H2,(H,29,33)(H,28,31,32) RTZRQMLMSQRVKR-UHFFFAOYSA-N 625247 US20230322767, Example 73::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Casein kinase I isoform delta Homo sapiens 5.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625247&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 169422882 485207593 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332911 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2/c1-16(17-7-9-20(28)10-8-17)26(33)32-22-15-19(11-13-29-22)25-23(18-5-3-2-4-6-18)24-21(31-25)12-14-30-27(24)34/h2-11,13,15-16,31H,12,14H2,1H3,(H,30,34)(H,29,32,33) IQZPQUJCVSQAHV-UHFFFAOYSA-N 625248 US20230322767, Example 74::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 1.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625248&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687206 485207594 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332912 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2/c1-16(17-7-9-20(28)10-8-17)26(33)32-22-15-19(11-13-29-22)25-23(18-5-3-2-4-6-18)24-21(31-25)12-14-30-27(24)34/h2-11,13,15-16,31H,12,14H2,1H3,(H,30,34)(H,29,32,33) IQZPQUJCVSQAHV-UHFFFAOYSA-N 625248 US20230322767, Example 74::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625248&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687206 485207594 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332913 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-10,12,14,20,22,34H,11,13,15H2,(H,33,37)(H,32,35,36) NWFHVGCAXUNSLN-UHFFFAOYSA-N 625249 US20230322767, Example 75::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625249&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687045 485207595 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332914 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-10,12,14,20,22,34H,11,13,15H2,(H,33,37)(H,32,35,36) NWFHVGCAXUNSLN-UHFFFAOYSA-N 625249 US20230322767, Example 75::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625249&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687045 485207595 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332915 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2cc[nH]c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-14,20,22,34H,15H2,(H,33,37)(H,32,35,36) GUSYZMMWQWPZSF-UHFFFAOYSA-N 625250 US20230322767, Example 76::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625250&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 169422883 485207596 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332916 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2cc[nH]c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-14,20,22,34H,15H2,(H,33,37)(H,32,35,36) GUSYZMMWQWPZSF-UHFFFAOYSA-N 625250 US20230322767, Example 76::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625250&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 169422883 485207596 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332917 Cn1cc(Cl)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H20ClFN4O2/c1-33-15-20(28)26-24(27(33)35)23(17-5-3-2-4-6-17)25(32-26)18-11-12-30-21(14-18)31-22(34)13-16-7-9-19(29)10-8-16/h2-12,14-15,32H,13H2,1H3,(H,30,31,34) MXKTVDFRBVSJHZ-UHFFFAOYSA-N 625251 US20230322767, Example 79::N-[4-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 5.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625251&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687026 485207597 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332918 Cn1cc(Cl)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H20ClFN4O2/c1-33-15-20(28)26-24(27(33)35)23(17-5-3-2-4-6-17)25(32-26)18-11-12-30-21(14-18)31-22(34)13-16-7-9-19(29)10-8-16/h2-12,14-15,32H,13H2,1H3,(H,30,31,34) MXKTVDFRBVSJHZ-UHFFFAOYSA-N 625251 US20230322767, Example 79::N-[4-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625251&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687026 485207597 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332919 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H27F3N4O2/c1-38-30(40)27-23(17-31(38)12-13-31)36-28(26(27)19-5-3-2-4-6-19)20-11-14-35-25(15-20)37-29(39)22(16-24(33)34)18-7-9-21(32)10-8-18/h2-11,14-15,22,24,36H,12-13,16-17H2,1H3,(H,35,37,39) KEZOOBHJFUUXAY-UHFFFAOYSA-N 625252 US20230322767, Example 80::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625252&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687187 485207598 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332920 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H27F3N4O2/c1-38-30(40)27-23(17-31(38)12-13-31)36-28(26(27)19-5-3-2-4-6-19)20-11-14-35-25(15-20)37-29(39)22(16-24(33)34)18-7-9-21(32)10-8-18/h2-11,14-15,22,24,36H,12-13,16-17H2,1H3,(H,35,37,39) KEZOOBHJFUUXAY-UHFFFAOYSA-N 625252 US20230322767, Example 80::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 5.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625252&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687187 485207598 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332921 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F4N4O2/c1-39-30(41)27-23(16-31(39)11-12-31)37-28(26(27)18-4-8-21(33)9-5-18)19-10-13-36-25(14-19)38-29(40)22(15-24(34)35)17-2-6-20(32)7-3-17/h2-10,13-14,22,24,37H,11-12,15-16H2,1H3,(H,36,38,40) JIIUKZNINHUSRU-UHFFFAOYSA-N 625253 US20230322767, Example 81::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3′-(4-fluorophenyl)-5′-methyl-4′-oxo-1′,4′,5′,7′-tetrahydro-spiro[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625253&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687097 485207599 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332922 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F4N4O2/c1-39-30(41)27-23(16-31(39)11-12-31)37-28(26(27)18-4-8-21(33)9-5-18)19-10-13-36-25(14-19)38-29(40)22(15-24(34)35)17-2-6-20(32)7-3-17/h2-10,13-14,22,24,37H,11-12,15-16H2,1H3,(H,36,38,40) JIIUKZNINHUSRU-UHFFFAOYSA-N 625253 US20230322767, Example 81::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3′-(4-fluorophenyl)-5′-methyl-4′-oxo-1′,4′,5′,7′-tetrahydro-spiro[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625253&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687097 485207599 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332923 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-21-25(27(35)33-28)24(18-6-4-3-5-7-18)26(31-21)19-12-13-30-22(15-19)32-23(34)14-17-8-10-20(29)11-9-17/h3-13,15,31H,14,16H2,1-2H3,(H,33,35)(H,30,32,34) KUWRDHFUGZPJEA-UHFFFAOYSA-N 625254 US20230322767, Example 82::N-[4-(6,6-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 1.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625254&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687141 485207600 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332924 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-21-25(27(35)33-28)24(18-6-4-3-5-7-18)26(31-21)19-12-13-30-22(15-19)32-23(34)14-17-8-10-20(29)11-9-17/h3-13,15,31H,14,16H2,1-2H3,(H,33,35)(H,30,32,34) KUWRDHFUGZPJEA-UHFFFAOYSA-N 625254 US20230322767, Example 82::N-[4-(6,6-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 2.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625254&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687141 485207600 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332925 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-9-20(30)10-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-7-19(29)8-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) QLCNXGDPIFBNEO-UHFFFAOYSA-N 625255 US20230322767, Example 83::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform alpha Homo sapiens 1.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625255&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687130 485207601 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332926 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-9-20(30)10-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-7-19(29)8-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) QLCNXGDPIFBNEO-UHFFFAOYSA-N 625255 US20230322767, Example 83::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform delta Homo sapiens 3.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625255&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687130 485207601 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332927 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1F)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 |(-9.07,-2.26,;-8.3,-.92,;-9.83,-.51,;-6.96,-1.69,;-5.63,-.92,;-4.16,-1.4,;-3.26,-.15,;-4.16,1.09,;-5.63,.62,;-6.96,1.39,;-6.96,2.93,;-8.3,.62,;-3.69,2.56,;-4.72,3.7,;-4.24,5.17,;-2.74,5.49,;-1.71,4.34,;-2.18,2.88,;-1.15,1.73,;-1.72,-.15,;-.95,1.18,;.59,1.18,;1.36,-.15,;.59,-1.49,;1.36,-2.82,;2.9,-2.82,;3.67,-1.49,;3.67,-4.15,;5.21,-4.15,;5.98,-2.82,;7.52,-2.82,;8.29,-4.15,;9.83,-4.15,;7.52,-5.49,;5.98,-5.49,;-.95,-1.49,)| InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(19-5-3-4-6-20(19)30)26(32-21)17-11-12-31-22(14-17)33-23(35)13-16-7-9-18(29)10-8-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) XKQBNZMXBOTZTP-UHFFFAOYSA-N 625256 US20230322767, Example 84::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform alpha Homo sapiens 3.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625256&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687176 485207602 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332928 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1F)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 |(-9.07,-2.26,;-8.3,-.92,;-9.83,-.51,;-6.96,-1.69,;-5.63,-.92,;-4.16,-1.4,;-3.26,-.15,;-4.16,1.09,;-5.63,.62,;-6.96,1.39,;-6.96,2.93,;-8.3,.62,;-3.69,2.56,;-4.72,3.7,;-4.24,5.17,;-2.74,5.49,;-1.71,4.34,;-2.18,2.88,;-1.15,1.73,;-1.72,-.15,;-.95,1.18,;.59,1.18,;1.36,-.15,;.59,-1.49,;1.36,-2.82,;2.9,-2.82,;3.67,-1.49,;3.67,-4.15,;5.21,-4.15,;5.98,-2.82,;7.52,-2.82,;8.29,-4.15,;9.83,-4.15,;7.52,-5.49,;5.98,-5.49,;-.95,-1.49,)| InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(19-5-3-4-6-20(19)30)26(32-21)17-11-12-31-22(14-17)33-23(35)13-16-7-9-18(29)10-8-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) XKQBNZMXBOTZTP-UHFFFAOYSA-N 625256 US20230322767, Example 84::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform delta Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625256&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687176 485207602 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332929 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccc(F)c1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-4-3-5-20(30)13-17)26(32-21)18-10-11-31-22(14-18)33-23(35)12-16-6-8-19(29)9-7-16/h3-11,13-14,32H,12,15H2,1-2H3,(H,34,36)(H,31,33,35) IANCPMFLRNSETO-UHFFFAOYSA-N 625257 US20230322767, Example 85::2-(4-fluorophenyl)-N-{4-[3-(3-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform alpha Homo sapiens 1.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625257&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687048 485207603 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332930 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccc(F)c1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-4-3-5-20(30)13-17)26(32-21)18-10-11-31-22(14-18)33-23(35)12-16-6-8-19(29)9-7-16/h3-11,13-14,32H,12,15H2,1-2H3,(H,34,36)(H,31,33,35) IANCPMFLRNSETO-UHFFFAOYSA-N 625257 US20230322767, Example 85::2-(4-fluorophenyl)-N-{4-[3-(3-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform delta Homo sapiens 3.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625257&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687048 485207603 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332931 Cc1cccc(c1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-5-4-6-19(13-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-11-12-31-23(15-20)33-24(35)14-18-7-9-21(30)10-8-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) VKLWOKCJHQIGOC-UHFFFAOYSA-N 625258 US20230322767, Example 86::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625258&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686988 485207604 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332932 Cc1cccc(c1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-5-4-6-19(13-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-11-12-31-23(15-20)33-24(35)14-18-7-9-21(30)10-8-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) VKLWOKCJHQIGOC-UHFFFAOYSA-N 625258 US20230322767, Example 86::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 5.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625258&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686988 485207604 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332933 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccccc1F)c1ccc(F)cc1 |(2.88,-5.51,;3.67,-4.13,;2.9,-2.8,;3.67,-1.47,;1.36,-2.8,;.59,-1.47,;-.95,-1.47,;-1.72,-.13,;-.95,1.2,;.59,1.2,;1.36,-.13,;-3.26,-.13,;-4.16,-1.38,;-5.63,-.9,;-6.96,-1.67,;-8.3,-.9,;-9.07,-2.24,;-9.83,-.49,;-8.3,.64,;-6.96,1.41,;-6.96,2.95,;-5.63,.64,;-4.16,1.11,;-3.69,2.58,;-4.72,3.72,;-4.24,5.19,;-2.74,5.51,;-1.71,4.36,;-2.18,2.9,;-1.15,1.75,;5.21,-4.13,;5.98,-2.8,;7.52,-2.8,;8.29,-4.13,;9.83,-4.13,;7.52,-5.47,;5.98,-5.47,)| InChI=1S/C29H26F2N4O2/c1-16(17-8-10-19(30)11-9-17)27(36)34-23-14-18(12-13-32-23)26-24(20-6-4-5-7-21(20)31)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) CESMQOAMBJTRME-UHFFFAOYSA-N 625259 US20230322767, Example 87::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625259&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687062 485207605 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332934 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccccc1F)c1ccc(F)cc1 |(2.88,-5.51,;3.67,-4.13,;2.9,-2.8,;3.67,-1.47,;1.36,-2.8,;.59,-1.47,;-.95,-1.47,;-1.72,-.13,;-.95,1.2,;.59,1.2,;1.36,-.13,;-3.26,-.13,;-4.16,-1.38,;-5.63,-.9,;-6.96,-1.67,;-8.3,-.9,;-9.07,-2.24,;-9.83,-.49,;-8.3,.64,;-6.96,1.41,;-6.96,2.95,;-5.63,.64,;-4.16,1.11,;-3.69,2.58,;-4.72,3.72,;-4.24,5.19,;-2.74,5.51,;-1.71,4.36,;-2.18,2.9,;-1.15,1.75,;5.21,-4.13,;5.98,-2.8,;7.52,-2.8,;8.29,-4.13,;9.83,-4.13,;7.52,-5.47,;5.98,-5.47,)| InChI=1S/C29H26F2N4O2/c1-16(17-8-10-19(30)11-9-17)27(36)34-23-14-18(12-13-32-23)26-24(20-6-4-5-7-21(20)31)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) CESMQOAMBJTRME-UHFFFAOYSA-N 625259 US20230322767, Example 87::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide Casein kinase I isoform delta Homo sapiens 13.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625259&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687062 485207605 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332935 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccc(C)c1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-6-5-7-20(14-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-12-13-32-24(15-21)34-28(36)18(2)19-8-10-22(31)11-9-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) DPXSVWSOUOLCJN-UHFFFAOYSA-N 625260 US20230322767, Example 88::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 8.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625260&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687154 485207606 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332936 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccc(C)c1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-6-5-7-20(14-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-12-13-32-24(15-21)34-28(36)18(2)19-8-10-22(31)11-9-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) DPXSVWSOUOLCJN-UHFFFAOYSA-N 625260 US20230322767, Example 88::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625260&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687154 485207606 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332937 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(Cl)cc1)c1ccc(F)cc1 InChI=1S/C29H26ClFN4O2/c1-16(17-6-10-21(31)11-7-17)27(36)34-23-14-19(12-13-32-23)26-24(18-4-8-20(30)9-5-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NXZVSYWCPKVCRD-UHFFFAOYSA-N 625261 US20230322767, Example 89::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 6.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625261&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687199 485207607 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332938 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(Cl)cc1)c1ccc(F)cc1 InChI=1S/C29H26ClFN4O2/c1-16(17-6-10-21(31)11-7-17)27(36)34-23-14-19(12-13-32-23)26-24(18-4-8-20(30)9-5-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NXZVSYWCPKVCRD-UHFFFAOYSA-N 625261 US20230322767, Example 89::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625261&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687199 485207607 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332939 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(Cl)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24ClFN4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-7-19(29)8-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-9-20(30)10-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) CGUGCENQQQHEFN-UHFFFAOYSA-N 625262 US20230322767, Example 90::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 3.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625262&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687239 485207608 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332940 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(Cl)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24ClFN4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-7-19(29)8-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-9-20(30)10-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) CGUGCENQQQHEFN-UHFFFAOYSA-N 625262 US20230322767, Example 90::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 4.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625262&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687239 485207608 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332941 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(C)cc1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-5-7-20(8-6-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-13-14-32-24(15-21)34-28(36)18(2)19-9-11-22(31)12-10-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) WXFWDDXWJIXSSH-UHFFFAOYSA-N 625263 US20230322767, Example 91::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 7.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625263&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687214 485207609 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332942 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(C)cc1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-5-7-20(8-6-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-13-14-32-24(15-21)34-28(36)18(2)19-9-11-22(31)12-10-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) WXFWDDXWJIXSSH-UHFFFAOYSA-N 625263 US20230322767, Example 91::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 7.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625263&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687214 485207609 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332943 Cc1ccc(cc1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-4-8-19(9-5-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-12-13-31-23(15-20)33-24(35)14-18-6-10-21(30)11-7-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) QBGYCMODWQDKCX-UHFFFAOYSA-N 625264 US20230322767, Example 92::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625264&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686951 485207610 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332944 Cc1ccc(cc1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-4-8-19(9-5-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-12-13-31-23(15-20)33-24(35)14-18-6-10-21(30)11-7-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) QBGYCMODWQDKCX-UHFFFAOYSA-N 625264 US20230322767, Example 92::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 5.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625264&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686951 485207610 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332945 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H24FN5O2/c1-27(2)14-20-24(26(35)33-27)23(18-4-3-10-29-15-18)25(31-20)17-9-11-30-21(13-17)32-22(34)12-16-5-7-19(28)8-6-16/h3-11,13,15,31H,12,14H2,1-2H3,(H,33,35)(H,30,32,34) UHKJLPKHZOTEFL-UHFFFAOYSA-N 625265 US20230322767, Example 93::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625265&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687029 485207611 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332946 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H24FN5O2/c1-27(2)14-20-24(26(35)33-27)23(18-4-3-10-29-15-18)25(31-20)17-9-11-30-21(13-17)32-22(34)12-16-5-7-19(28)8-6-16/h3-11,13,15,31H,12,14H2,1-2H3,(H,33,35)(H,30,32,34) UHKJLPKHZOTEFL-UHFFFAOYSA-N 625265 US20230322767, Example 93::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 9.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625265&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687029 485207611 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332947 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform alpha Homo sapiens 3.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332948 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform delta Homo sapiens 3.20 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332949 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform alpha Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332950 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform delta Homo sapiens 4.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332951 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform alpha Homo sapiens 1.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332952 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Casein kinase I isoform delta Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332953 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform alpha Homo sapiens 8.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332954 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332955 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform alpha Homo sapiens 71.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332956 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform delta Homo sapiens 19.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332957 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform alpha Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332958 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Casein kinase I isoform delta Homo sapiens 5.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332959 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625272 US20230322767, Example 100::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625272&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207614 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332960 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625272 US20230322767, Example 100::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 8.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625272&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207614 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332961 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625273 US20230322767, Example 101::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625273&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207615 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332962 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625273 US20230322767, Example 101::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 5.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625273&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207615 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332963 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625274 US20230322767, Example 102::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 1.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625274&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207616 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332964 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625274 US20230322767, Example 102::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625274&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207616 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332965 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform alpha Homo sapiens 5.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332966 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332967 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform alpha Homo sapiens 7.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332968 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform delta Homo sapiens 5.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332969 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform alpha Homo sapiens 0.710 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332970 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Casein kinase I isoform delta Homo sapiens 1.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332971 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(Cl)c1)c1ccc(F)cc1 InChI=1S/C28H22ClFN4O2/c1-16(17-6-8-21(30)9-7-17)27(35)33-23-15-19(10-12-31-23)26-24(18-4-3-5-20(29)14-18)25-22(32-26)11-13-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) VBCYKNRNAQCIRZ-UHFFFAOYSA-N 625278 US20230322767, Example 106::N-{4-[3-(3-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 9.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625278&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687191 485207618 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332972 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(Cl)c1)c1ccc(F)cc1 InChI=1S/C28H22ClFN4O2/c1-16(17-6-8-21(30)9-7-17)27(35)33-23-15-19(10-12-31-23)26-24(18-4-3-5-20(29)14-18)25-22(32-26)11-13-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) VBCYKNRNAQCIRZ-UHFFFAOYSA-N 625278 US20230322767, Example 106::N-{4-[3-(3-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625278&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687191 485207618 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332973 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625279 US20230322767, Example 107::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 3.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625279&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207619 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332974 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625279 US20230322767, Example 107::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625279&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207619 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332975 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625280 US20230322767, Example 108::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 15.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625280&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207620 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332976 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625280 US20230322767, Example 108::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 9.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625280&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207620 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332977 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625281 US20230322767, Example 109::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 2.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625281&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207621 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332978 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625281 US20230322767, Example 109::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 3.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625281&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207621 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332979 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1F)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C27H21F2N5O2/c1-15(16-5-7-18(28)8-6-16)26(35)33-21-14-17(9-12-30-21)24-22(19-4-3-11-31-25(19)29)23-20(32-24)10-13-34(2)27(23)36/h3-15,32H,1-2H3,(H,30,33,35) BKURPYZERHHSEV-UHFFFAOYSA-N 625282 US20230322767, Example 110::2-(4-fluorophenyl)-N-{4-[3-(2-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 30.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625282&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687135 485207622 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332980 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1F)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C27H21F2N5O2/c1-15(16-5-7-18(28)8-6-16)26(35)33-21-14-17(9-12-30-21)24-22(19-4-3-11-31-25(19)29)23-20(32-24)10-13-34(2)27(23)36/h3-15,32H,1-2H3,(H,30,33,35) BKURPYZERHHSEV-UHFFFAOYSA-N 625282 US20230322767, Example 110::2-(4-fluorophenyl)-N-{4-[3-(2-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 21.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625282&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687135 485207622 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332981 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1C)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H24FN5O2/c1-16(18-6-8-20(29)9-7-18)27(35)33-23-15-19(10-13-31-23)26-24(21-5-4-12-30-17(21)2)25-22(32-26)11-14-34(3)28(25)36/h4-16,32H,1-3H3,(H,31,33,35) SPSYPMSEFLCIIR-UHFFFAOYSA-N 625283 US20230322767, Example 111::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methylphenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 37.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625283&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 169285969 485207623 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332982 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1C)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H24FN5O2/c1-16(18-6-8-20(29)9-7-18)27(35)33-23-15-19(10-13-31-23)26-24(21-5-4-12-30-17(21)2)25-22(32-26)11-14-34(3)28(25)36/h4-16,32H,1-3H3,(H,31,33,35) SPSYPMSEFLCIIR-UHFFFAOYSA-N 625283 US20230322767, Example 111::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methylphenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 22.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625283&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 169285969 485207623 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332983 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1Cl)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H22ClFN4O2/c1-16(17-7-9-19(30)10-8-17)27(35)33-23-15-18(11-13-31-23)26-24(20-5-3-4-6-21(20)29)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ASSQRJJOLODGSX-UHFFFAOYSA-N 625284 US20230322767, Example 112::N-{4-[3-(2-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 23.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625284&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687194 485207624 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332984 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1Cl)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H22ClFN4O2/c1-16(17-7-9-19(30)10-8-17)27(35)33-23-15-18(11-13-31-23)26-24(20-5-3-4-6-21(20)29)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ASSQRJJOLODGSX-UHFFFAOYSA-N 625284 US20230322767, Example 112::N-{4-[3-(2-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625284&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687194 485207624 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332985 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(O)c1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-6-8-20(29)9-7-17)27(35)32-23-15-19(10-12-30-23)26-24(18-4-3-5-21(34)14-18)25-22(31-26)11-13-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) DCGFWGFEATUMQK-UHFFFAOYSA-N 625285 US20230322767, Example 113::2-(4-fluorophenyl)-N-{4-[3-(3-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 32.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625285&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686978 485207625 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332986 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(O)c1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-6-8-20(29)9-7-17)27(35)32-23-15-19(10-12-30-23)26-24(18-4-3-5-21(34)14-18)25-22(31-26)11-13-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) DCGFWGFEATUMQK-UHFFFAOYSA-N 625285 US20230322767, Example 113::2-(4-fluorophenyl)-N-{4-[3-(3-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 33.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625285&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686978 485207625 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332987 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-6-19(29)7-4-16)27(36)34-23-14-18(9-11-32-23)26-24(17-5-8-20(30)21(31)13-17)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) HWQQHGYFYYEJPD-UHFFFAOYSA-N 625286 US20230322767, Example 114::N-{4-[3-(3,4-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625286&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687022 485207626 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332988 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-6-19(29)7-4-16)27(36)34-23-14-18(9-11-32-23)26-24(17-5-8-20(30)21(31)13-17)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) HWQQHGYFYYEJPD-UHFFFAOYSA-N 625286 US20230322767, Example 114::N-{4-[3-(3,4-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 6.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625286&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687022 485207626 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332989 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccoc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) KVANAHYNCXXVFJ-UHFFFAOYSA-N 625287 US20230322767, Example 115::2-(4-fluorophenyl)-N-{4-[3-(3-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625287&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687067 485207627 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332990 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccoc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) KVANAHYNCXXVFJ-UHFFFAOYSA-N 625287 US20230322767, Example 115::2-(4-fluorophenyl)-N-{4-[3-(3-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 5.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625287&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687067 485207627 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332991 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccco1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) VACLTQRSBVUDMW-UHFFFAOYSA-N 625288 US20230322767, Example 116::2-(4-fluorophenyl)-N-{4-[3-(2-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 3.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625288&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687040 485207628 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332992 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccco1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) VACLTQRSBVUDMW-UHFFFAOYSA-N 625288 US20230322767, Example 116::2-(4-fluorophenyl)-N-{4-[3-(2-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 7.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625288&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687040 485207628 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332993 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)c(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H20F4N4O2/c1-14(15-3-5-18(29)6-4-15)27(37)35-22-13-16(7-9-33-22)26-23(17-11-19(30)25(32)20(31)12-17)24-21(34-26)8-10-36(2)28(24)38/h3-14,34H,1-2H3,(H,33,35,37) CUOVQWSQXJWUPZ-UHFFFAOYSA-N 625289 US20230322767, Example 117::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3,4,5-trifluorophenyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625289&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687091 485207629 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332994 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)c(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H20F4N4O2/c1-14(15-3-5-18(29)6-4-15)27(37)35-22-13-16(7-9-33-22)26-23(17-11-19(30)25(32)20(31)12-17)24-21(34-26)8-10-36(2)28(24)38/h3-14,34H,1-2H3,(H,33,35,37) CUOVQWSQXJWUPZ-UHFFFAOYSA-N 625289 US20230322767, Example 117::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3,4,5-trifluorophenyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 7.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625289&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687091 485207629 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332995 Cn1ccc2[nH]c(c(-c3cccnc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H22F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-13,15,20,22,34H,14H2,1H3,(H,33,35,37) WLAQANVUFCSRMA-UHFFFAOYSA-N 625290 US20230322767, Example 118::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 8.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625290&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686987 485207630 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332996 Cn1ccc2[nH]c(c(-c3cccnc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H22F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-13,15,20,22,34H,14H2,1H3,(H,33,35,37) WLAQANVUFCSRMA-UHFFFAOYSA-N 625290 US20230322767, Example 118::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625290&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686987 485207630 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332997 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(O)cc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-3-7-20(29)8-4-17)27(35)32-23-15-19(11-13-30-23)26-24(18-5-9-21(34)10-6-18)25-22(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) RKWUJVALCBMSHZ-UHFFFAOYSA-N 625291 US20230322767, Example 119::2-(4-fluorophenyl)-N-{4-[3-(4-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 15.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625291&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687217 485207631 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1332998 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(O)cc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-3-7-20(29)8-4-17)27(35)32-23-15-19(11-13-30-23)26-24(18-5-9-21(34)10-6-18)25-22(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) RKWUJVALCBMSHZ-UHFFFAOYSA-N 625291 US20230322767, Example 119::2-(4-fluorophenyl)-N-{4-[3-(4-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625291&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687217 485207631 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1332999 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1F)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.38,2.6,;-1.29,1.51,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C28H21F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-14-19(30)7-8-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) CKWPZOKUIUDWSA-UHFFFAOYSA-N 625292 US20230322767, Example 120::N-{4-[3-(2,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 6.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625292&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687142 485207632 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333000 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1F)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.38,2.6,;-1.29,1.51,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C28H21F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-14-19(30)7-8-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) CKWPZOKUIUDWSA-UHFFFAOYSA-N 625292 US20230322767, Example 120::N-{4-[3-(2,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 8.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625292&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687142 485207632 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333001 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)cc(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-5-19(29)6-4-16)27(36)34-23-13-17(7-9-32-23)26-24(18-11-20(30)14-21(31)12-18)25-22(33-26)8-10-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) VMRHBZTUDNJLEK-UHFFFAOYSA-N 625293 US20230322767, Example 121::N-{4-[3-(3,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 7.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625293&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687080 485207633 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333002 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)cc(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-5-19(29)6-4-16)27(36)34-23-13-17(7-9-32-23)26-24(18-11-20(30)14-21(31)12-18)25-22(33-26)8-10-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) VMRHBZTUDNJLEK-UHFFFAOYSA-N 625293 US20230322767, Example 121::N-{4-[3-(3,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 13.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625293&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687080 485207633 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333003 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(Cl)s1)c1ccc(F)cc1 InChI=1S/C26H20ClFN4O2S/c1-14(15-3-5-17(28)6-4-15)25(33)31-21-13-16(9-11-29-21)24-23(19-7-8-20(27)35-19)22-18(30-24)10-12-32(2)26(22)34/h3-14,30H,1-2H3,(H,29,31,33) LDHDORYQIJLGSC-UHFFFAOYSA-N 625294 US20230322767, Example 122::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 3.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625294&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686979 485207634 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333004 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(Cl)s1)c1ccc(F)cc1 InChI=1S/C26H20ClFN4O2S/c1-14(15-3-5-17(28)6-4-15)25(33)31-21-13-16(9-11-29-21)24-23(19-7-8-20(27)35-19)22-18(30-24)10-12-32(2)26(22)34/h3-14,30H,1-2H3,(H,29,31,33) LDHDORYQIJLGSC-UHFFFAOYSA-N 625294 US20230322767, Example 122::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 9.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625294&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686979 485207634 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333005 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1C#N)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.34,2.91,;-.74,3.45,;.69,3.96,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C29H22FN5O2/c1-17(18-7-9-21(30)10-8-18)28(36)34-24-15-19(11-13-32-24)27-25(22-6-4-3-5-20(22)16-31)26-23(33-27)12-14-35(2)29(26)37/h3-15,17,33H,1-2H3,(H,32,34,36) QRVYIZSFRSIONY-UHFFFAOYSA-N 625295 US20230322767, Example 123::N-{4-[3-(2-cyanophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 25.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625295&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686955 485207635 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333006 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1C#N)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.34,2.91,;-.74,3.45,;.69,3.96,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C29H22FN5O2/c1-17(18-7-9-21(30)10-8-18)28(36)34-24-15-19(11-13-32-24)27-25(22-6-4-3-5-20(22)16-31)26-23(33-27)12-14-35(2)29(26)37/h3-15,17,33H,1-2H3,(H,32,34,36) QRVYIZSFRSIONY-UHFFFAOYSA-N 625295 US20230322767, Example 123::N-{4-[3-(2-cyanophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 22.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625295&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686955 485207635 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333007 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1O)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.38,2.95,;-1.29,1.86,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C28H23FN4O3/c1-16(17-7-9-19(29)10-8-17)27(35)32-23-15-18(11-13-30-23)26-24(20-5-3-4-6-22(20)34)25-21(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) UGZCBAQQMBKAOK-UHFFFAOYSA-N 625296 US20230322767, Example 124::2-(4-fluorophenyl)-N-{4-[3-(2-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625296&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687124 485207636 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333008 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1O)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.38,2.95,;-1.29,1.86,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C28H23FN4O3/c1-16(17-7-9-19(29)10-8-17)27(35)32-23-15-18(11-13-30-23)26-24(20-5-3-4-6-22(20)34)25-21(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) UGZCBAQQMBKAOK-UHFFFAOYSA-N 625296 US20230322767, Example 124::2-(4-fluorophenyl)-N-{4-[3-(2-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625296&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687124 485207636 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333009 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(C)s1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2S/c1-15-4-9-21(35-15)24-23-20(11-13-32(3)27(23)34)30-25(24)18-10-12-29-22(14-18)31-26(33)16(2)17-5-7-19(28)8-6-17/h4-14,16,30H,1-3H3,(H,29,31,33) JIUXQQJKSDSLKZ-UHFFFAOYSA-N 625297 US20230322767, Example 125::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(5-methyl-2-thienyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 3.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625297&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687197 485207637 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333010 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(C)s1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2S/c1-15-4-9-21(35-15)24-23-20(11-13-32(3)27(23)34)30-25(24)18-10-12-29-22(14-18)31-26(33)16(2)17-5-7-19(28)8-6-17/h4-14,16,30H,1-3H3,(H,29,31,33) JIUXQQJKSDSLKZ-UHFFFAOYSA-N 625297 US20230322767, Example 125::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(5-methyl-2-thienyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 5.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625297&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687197 485207637 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333011 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccnc(N)c1)c1ccc(F)cc1 InChI=1S/C27H23FN6O2/c1-15(16-3-5-19(28)6-4-16)26(35)33-22-14-18(8-11-31-22)25-23(17-7-10-30-21(29)13-17)24-20(32-25)9-12-34(2)27(24)36/h3-15,32H,1-2H3,(H2,29,30)(H,31,33,35) PPUNDPQNOCBVKW-UHFFFAOYSA-N 625298 US20230322767, Example 126::N-{4-[3-(2-aminopyridin-4-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 55.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625298&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687010 485207638 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333012 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccnc(N)c1)c1ccc(F)cc1 InChI=1S/C27H23FN6O2/c1-15(16-3-5-19(28)6-4-16)26(35)33-22-14-18(8-11-31-22)25-23(17-7-10-30-21(29)13-17)24-20(32-25)9-12-34(2)27(24)36/h3-15,32H,1-2H3,(H2,29,30)(H,31,33,35) PPUNDPQNOCBVKW-UHFFFAOYSA-N 625298 US20230322767, Example 126::N-{4-[3-(2-aminopyridin-4-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 63.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625298&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687010 485207638 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333013 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1C#N)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.34,2.56,;-.92,1.64,;-.37,-.02,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C29H21F2N5O2/c1-16(17-3-6-20(30)7-4-17)28(37)35-24-13-18(9-11-33-24)27-25(22-14-21(31)8-5-19(22)15-32)26-23(34-27)10-12-36(2)29(26)38/h3-14,16,34H,1-2H3,(H,33,35,37) RYYNYPNIEUPDOA-UHFFFAOYSA-N 625299 US20230322767, Example 127::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 33.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625299&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687212 485207639 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333014 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1C#N)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.34,2.56,;-.92,1.64,;-.37,-.02,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C29H21F2N5O2/c1-16(17-3-6-20(30)7-4-17)28(37)35-24-13-18(9-11-33-24)27-25(22-14-21(31)8-5-19(22)15-32)26-23(34-27)10-12-36(2)29(26)38/h3-14,16,34H,1-2H3,(H,33,35,37) RYYNYPNIEUPDOA-UHFFFAOYSA-N 625299 US20230322767, Example 127::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 33.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625299&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687212 485207639 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333015 CN1CCc2[nH]c(c(c2C1=O)-c1cc(F)ccc1C#N)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-7.42,3.68,;-6.09,2.91,;-6.09,1.37,;-4.75,.6,;-3.42,1.37,;-1.95,.89,;-1.05,2.14,;-1.95,3.38,;-3.42,2.91,;-4.75,3.68,;-4.75,5.22,;-1.56,4.87,;-2.65,5.96,;-2.25,7.45,;-3.34,8.53,;-.76,7.84,;.33,6.75,;-.03,5.23,;1.06,4.14,;2.15,3.05,;.49,2.14,;1.26,3.47,;2.8,3.47,;3.57,2.14,;2.8,.8,;3.57,-.53,;2.8,-1.87,;1.26,-1.87,;3.57,-3.2,;5.11,-3.2,;5.88,-4.53,;5.11,-5.87,;7.42,-4.53,;2.8,-4.53,;1.26,-4.53,;.49,-5.87,;1.26,-7.2,;.49,-8.53,;2.8,-7.2,;3.57,-5.87,;1.26,.8,)| InChI=1S/C30H23F4N5O2/c1-39-11-9-23-27(30(39)41)26(21-13-20(32)7-4-18(21)15-35)28(37-23)17-8-10-36-25(12-17)38-29(40)22(14-24(33)34)16-2-5-19(31)6-3-16/h2-8,10,12-13,22,24,37H,9,11,14H2,1H3,(H,36,38,40) UCWZHWFDHODGBP-UHFFFAOYSA-N 625300 US20230322767, Example 128::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625300&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687078 485207640 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333016 CN1CCc2[nH]c(c(c2C1=O)-c1cc(F)ccc1C#N)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-7.42,3.68,;-6.09,2.91,;-6.09,1.37,;-4.75,.6,;-3.42,1.37,;-1.95,.89,;-1.05,2.14,;-1.95,3.38,;-3.42,2.91,;-4.75,3.68,;-4.75,5.22,;-1.56,4.87,;-2.65,5.96,;-2.25,7.45,;-3.34,8.53,;-.76,7.84,;.33,6.75,;-.03,5.23,;1.06,4.14,;2.15,3.05,;.49,2.14,;1.26,3.47,;2.8,3.47,;3.57,2.14,;2.8,.8,;3.57,-.53,;2.8,-1.87,;1.26,-1.87,;3.57,-3.2,;5.11,-3.2,;5.88,-4.53,;5.11,-5.87,;7.42,-4.53,;2.8,-4.53,;1.26,-4.53,;.49,-5.87,;1.26,-7.2,;.49,-8.53,;2.8,-7.2,;3.57,-5.87,;1.26,.8,)| InChI=1S/C30H23F4N5O2/c1-39-11-9-23-27(30(39)41)26(21-13-20(32)7-4-18(21)15-35)28(37-23)17-8-10-36-25(12-17)38-29(40)22(14-24(33)34)16-2-5-19(31)6-3-16/h2-8,10,12-13,22,24,37H,9,11,14H2,1H3,(H,36,38,40) UCWZHWFDHODGBP-UHFFFAOYSA-N 625300 US20230322767, Example 128::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625300&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687078 485207640 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333017 CN1CCc2[nH]c(c(-c3cnc(C)s3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H24F3N5O2S/c1-14-32-13-20(38-14)24-23-19(8-10-35(2)27(23)37)33-25(24)16-7-9-31-22(11-16)34-26(36)18(12-21(29)30)15-3-5-17(28)6-4-15/h3-7,9,11,13,18,21,33H,8,10,12H2,1-2H3,(H,31,34,36) OPOQBSCRYUUEBT-UHFFFAOYSA-N 625301 US20230322767, Example 129::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methyl-1,3-thiazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 15.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625301&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687234 485207641 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333018 CN1CCc2[nH]c(c(-c3cnc(C)s3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H24F3N5O2S/c1-14-32-13-20(38-14)24-23-19(8-10-35(2)27(23)37)33-25(24)16-7-9-31-22(11-16)34-26(36)18(12-21(29)30)15-3-5-17(28)6-4-15/h3-7,9,11,13,18,21,33H,8,10,12H2,1-2H3,(H,31,34,36) OPOQBSCRYUUEBT-UHFFFAOYSA-N 625301 US20230322767, Example 129::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methyl-1,3-thiazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 13.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625301&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687234 485207641 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333019 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccs1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) NHWOIUQSMAGREQ-UHFFFAOYSA-N 625302 US20230322767, Example 130::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(2-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.40 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625302&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687175 485207642 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333020 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccs1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) NHWOIUQSMAGREQ-UHFFFAOYSA-N 625302 US20230322767, Example 130::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(2-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625302&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687175 485207642 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333021 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccsc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) GVIDEIQDBDMNLC-UHFFFAOYSA-N 625303 US20230322767, Example 131::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 7.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625303&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687112 485207643 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333022 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccsc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) GVIDEIQDBDMNLC-UHFFFAOYSA-N 625303 US20230322767, Example 131::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 10.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625303&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687112 485207643 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333023 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1C)c1ccc(F)cc1 InChI=1S/C23H21FN4O2/c1-13(15-4-6-17(24)7-5-15)22(29)27-19-12-16(8-10-25-19)21-14(2)20-18(26-21)9-11-28(3)23(20)30/h4-13,26H,1-3H3,(H,25,27,29) XPNJMLZYFXKLLR-UHFFFAOYSA-N 625304 US20230322767, Example 132::N-[4-(3,5-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 6.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625304&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687244 485207644 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333024 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1C)c1ccc(F)cc1 InChI=1S/C23H21FN4O2/c1-13(15-4-6-17(24)7-5-15)22(29)27-19-12-16(8-10-25-19)21-14(2)20-18(26-21)9-11-28(3)23(20)30/h4-13,26H,1-3H3,(H,25,27,29) XPNJMLZYFXKLLR-UHFFFAOYSA-N 625304 US20230322767, Example 132::N-[4-(3,5-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625304&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687244 485207644 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333025 Cn1ccc2[nH]c(c(-c3ccc(Cl)s3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H20ClF3N4O2S/c1-35-11-9-18-23(27(35)37)24(19-6-7-20(28)38-19)25(33-18)15-8-10-32-22(12-15)34-26(36)17(13-21(30)31)14-2-4-16(29)5-3-14/h2-12,17,21,33H,13H2,1H3,(H,32,34,36) RYHVMNZCJGRAGW-UHFFFAOYSA-N 625305 US20230322767, Example 133::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 2.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625305&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686965 485207645 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333026 Cn1ccc2[nH]c(c(-c3ccc(Cl)s3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H20ClF3N4O2S/c1-35-11-9-18-23(27(35)37)24(19-6-7-20(28)38-19)25(33-18)15-8-10-32-22(12-15)34-26(36)17(13-21(30)31)14-2-4-16(29)5-3-14/h2-12,17,21,33H,13H2,1H3,(H,32,34,36) RYHVMNZCJGRAGW-UHFFFAOYSA-N 625305 US20230322767, Example 133::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 4.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625305&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686965 485207645 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333027 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625306 US20230322767, Example 134::N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 5.50 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625306&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207646 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333028 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625306 US20230322767, Example 134::N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 7.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625306&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207646 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333029 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625307 US20230322767, Example 135::(-)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 7.80 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625307&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207647 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333030 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625307 US20230322767, Example 135::(-)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 5.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625307&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207647 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333031 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625308 US20230322767, Example 136::(+)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625308 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625308&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207648 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333032 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625308 US20230322767, Example 136::(+)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 2.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625308 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625308&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207648 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333033 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform alpha Homo sapiens 2.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333034 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform delta Homo sapiens 3.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333035 CN1CCc2[nH]c(c(-c3cscn3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C26H22F3N5O2S/c1-34-9-7-18-23(26(34)36)22(19-12-37-13-31-19)24(32-18)15-6-8-30-21(10-15)33-25(35)17(11-20(28)29)14-2-4-16(27)5-3-14/h2-6,8,10,12-13,17,20,32H,7,9,11H2,1H3,(H,30,33,35) DAVLHGUDTGYPHJ-UHFFFAOYSA-N 625310 US20230322767, Example 138::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(1,3-thiazol-4-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 8.90 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625310 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625310&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687127 485207650 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333036 CN1CCc2[nH]c(c(-c3cscn3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C26H22F3N5O2S/c1-34-9-7-18-23(26(34)36)22(19-12-37-13-31-19)24(32-18)15-6-8-30-21(10-15)33-25(35)17(11-20(28)29)14-2-4-16(27)5-3-14/h2-6,8,10,12-13,17,20,32H,7,9,11H2,1H3,(H,30,33,35) DAVLHGUDTGYPHJ-UHFFFAOYSA-N 625310 US20230322767, Example 138::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(1,3-thiazol-4-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 8.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625310 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625310&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687127 485207650 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333037 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H24F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-10,12,14,21,23,35H,11,13,15H2,1H3,(H,34,36,38) HTDCNRIYLUVMQJ-UHFFFAOYSA-N 625311 US20230322767, Example 139::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625311&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686984 485207651 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333038 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H24F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-10,12,14,21,23,35H,11,13,15H2,1H3,(H,34,36,38) HTDCNRIYLUVMQJ-UHFFFAOYSA-N 625311 US20230322767, Example 139::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 5.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625311&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686984 485207651 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333039 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H30FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-11,13,18,35H,12,14-17H2,1-2H3,(H,34,39)(H,33,36,38) HGJUNURCFJGYIC-UHFFFAOYSA-N 625312 US20230322767, Example 140::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Casein kinase I isoform alpha Homo sapiens 1.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625312 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625312&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687113 485207652 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333040 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H30FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-11,13,18,35H,12,14-17H2,1-2H3,(H,34,39)(H,33,36,38) HGJUNURCFJGYIC-UHFFFAOYSA-N 625312 US20230322767, Example 140::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Casein kinase I isoform delta Homo sapiens 1.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625312 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625312&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687113 485207652 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333041 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H32FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-12,14,19,35H,13,15-18H2,1-3H3,(H,34,36,39) KURMGXLJUFMRKC-UHFFFAOYSA-N 625313 US20230322767, Example 141::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Casein kinase I isoform alpha Homo sapiens 3.60 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625313&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687052 485207653 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333042 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H32FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-12,14,19,35H,13,15-18H2,1-3H3,(H,34,36,39) KURMGXLJUFMRKC-UHFFFAOYSA-N 625313 US20230322767, Example 141::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Casein kinase I isoform delta Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625313&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687052 485207653 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333043 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H28FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-13,15,18,35H,14,16-17H2,1-2H3,(H,34,39)(H,33,36,38) URJGMIVEJKRPDY-UHFFFAOYSA-N 625314 US20230322767, Example 142::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Casein kinase I isoform alpha Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625314&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687055 485207654 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333044 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H28FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-13,15,18,35H,14,16-17H2,1-2H3,(H,34,39)(H,33,36,38) URJGMIVEJKRPDY-UHFFFAOYSA-N 625314 US20230322767, Example 142::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Casein kinase I isoform delta Homo sapiens 3.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625314&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687055 485207654 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333045 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H30FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-15,19,35H,16-18H2,1-3H3,(H,34,36,39) IOTPYKAXEUJUIX-UHFFFAOYSA-N 625315 US20230322767, Example 143::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Casein kinase I isoform alpha Homo sapiens 4.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625315&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687074 485207655 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333046 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H30FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-15,19,35H,16-18H2,1-3H3,(H,34,36,39) IOTPYKAXEUJUIX-UHFFFAOYSA-N 625315 US20230322767, Example 143::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Casein kinase I isoform delta Homo sapiens 2.70 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625315&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687074 485207655 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333047 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(cc2)C(=O)N2CCNCC2)c1 InChI=1S/C32H31FN6O3/c1-38-15-11-25-29(32(38)42)28(21-6-8-24(33)9-7-21)30(36-25)23-10-12-35-26(19-23)37-27(40)18-20-2-4-22(5-3-20)31(41)39-16-13-34-14-17-39/h2-10,12,19,34,36H,11,13-18H2,1H3,(H,35,37,40) FUBHPUWOZAXCKP-UHFFFAOYSA-N 625316 US20230322767, Example 144::N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-[4-(piperazine-1-carbonyl)phenyl]acetamide Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625316 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625316&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686970 485207656 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333048 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(cc2)C(=O)N2CCNCC2)c1 InChI=1S/C32H31FN6O3/c1-38-15-11-25-29(32(38)42)28(21-6-8-24(33)9-7-21)30(36-25)23-10-12-35-26(19-23)37-27(40)18-20-2-4-22(5-3-20)31(41)39-16-13-34-14-17-39/h2-10,12,19,34,36H,11,13-18H2,1H3,(H,35,37,40) FUBHPUWOZAXCKP-UHFFFAOYSA-N 625316 US20230322767, Example 144::N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-[4-(piperazine-1-carbonyl)phenyl]acetamide Casein kinase I isoform delta Homo sapiens 3.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625316 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625316&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686970 485207656 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333049 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)nc1)c1ccc(F)cc1 InChI=1S/C27H21F2N5O2/c1-15(16-3-6-19(28)7-4-16)26(35)33-22-13-17(9-11-30-22)25-23(18-5-8-21(29)31-14-18)24-20(32-25)10-12-34(2)27(24)36/h3-15,32H,1-2H3,(H,30,33,35) NXHUBNJAPUQPMR-UHFFFAOYSA-N 625317 US20230322767, Example 145::2-(4-fluorophenyl)-N-{4-[3-(6-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 9.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625317 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625317&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687015 485207657 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333050 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)nc1)c1ccc(F)cc1 InChI=1S/C27H21F2N5O2/c1-15(16-3-6-19(28)7-4-16)26(35)33-22-13-17(9-11-30-22)25-23(18-5-8-21(29)31-14-18)24-20(32-25)10-12-34(2)27(24)36/h3-15,32H,1-2H3,(H,30,33,35) NXHUBNJAPUQPMR-UHFFFAOYSA-N 625317 US20230322767, Example 145::2-(4-fluorophenyl)-N-{4-[3-(6-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Casein kinase I isoform delta Homo sapiens 10.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625317 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625317&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687015 485207657 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333051 Cn1ccc2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H20FN5O2/c1-32-13-10-20-24(26(32)34)23(19-4-2-3-11-28-19)25(30-20)17-9-12-29-21(15-17)31-22(33)14-16-5-7-18(27)8-6-16/h2-13,15,30H,14H2,1H3,(H,29,31,33) OMNHTKCFSGFFKE-UHFFFAOYSA-N 625318 US20230322767, Example 146::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform alpha Homo sapiens 3.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625318&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687122 485207658 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333052 Cn1ccc2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H20FN5O2/c1-32-13-10-20-24(26(32)34)23(19-4-2-3-11-28-19)25(30-20)17-9-12-29-21(15-17)31-22(33)14-16-5-7-18(27)8-6-16/h2-13,15,30H,14H2,1H3,(H,29,31,33) OMNHTKCFSGFFKE-UHFFFAOYSA-N 625318 US20230322767, Example 146::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Casein kinase I isoform delta Homo sapiens 4.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625318&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687122 485207658 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333053 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform alpha Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333054 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform delta Homo sapiens 2.90 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333055 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform alpha Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333056 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform delta Homo sapiens 6.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333057 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform alpha Homo sapiens 3.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333058 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Casein kinase I isoform delta Homo sapiens 3.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333059 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625322 US20230322767, Example 150::(rac)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-tri methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform alpha Homo sapiens 4.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625322&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207660 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333060 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625322 US20230322767, Example 150::(rac)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-tri methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Casein kinase I isoform delta Homo sapiens 3.80 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625322&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207660 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333061 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625323 US20230322767, Example 151::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 1) Casein kinase I isoform alpha Homo sapiens 17.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625323 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625323&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207661 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333062 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625323 US20230322767, Example 151::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 1) Casein kinase I isoform delta Homo sapiens 19.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625323 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625323&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207661 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333063 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625324 US20230322767, Example 152::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 2) Casein kinase I isoform alpha Homo sapiens 4.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625324&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207662 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333064 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625324 US20230322767, Example 152::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 2) Casein kinase I isoform delta Homo sapiens 4.50 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625324&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207662 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333065 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333066 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform delta Homo sapiens 2.40 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333067 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform alpha Homo sapiens 5.10 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333068 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform delta Homo sapiens 6.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333069 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform alpha Homo sapiens 1.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333070 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Casein kinase I isoform delta Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333071 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C3CC3)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H27F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12,14,16,22-23,25,36H,10-11,13,15,17H2,(H,35,37,39) JVIJLVJHTLMUII-UHFFFAOYSA-N 625328 US20230322767, Example 156::(2RS)—N-(4-(5-cyclopropyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl)-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform alpha Homo sapiens 2.30 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625328&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162686952 485207664 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333072 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C3CC3)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H27F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12,14,16,22-23,25,36H,10-11,13,15,17H2,(H,35,37,39) JVIJLVJHTLMUII-UHFFFAOYSA-N 625328 US20230322767, Example 156::(2RS)—N-(4-(5-cyclopropyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl)-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform delta Homo sapiens 3.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625328&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162686952 485207664 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333073 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform alpha Homo sapiens 2.00 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333074 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform delta Homo sapiens 2.30 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333075 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform alpha Homo sapiens 3.20 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333076 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Casein kinase I isoform delta Homo sapiens 5.10 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333077 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C4CC4)c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C29H23FN4O2/c30-21-8-6-18(7-9-21)16-25(35)33-24-17-20(12-14-31-24)28-26(19-4-2-1-3-5-19)27-23(32-28)13-15-34(29(27)36)22-10-11-22/h1-9,12-15,17,22,32H,10-11,16H2,(H,31,33,35) YDSYMWHEHOEDFK-UHFFFAOYSA-N 625331 US20230322767, Example 159::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform alpha Homo sapiens 0.960 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625331&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687068 485207665 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333078 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C4CC4)c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C29H23FN4O2/c30-21-8-6-18(7-9-21)16-25(35)33-24-17-20(12-14-31-24)28-26(19-4-2-1-3-5-19)27-23(32-28)13-15-34(29(27)36)22-10-11-22/h1-9,12-15,17,22,32H,10-11,16H2,(H,31,33,35) YDSYMWHEHOEDFK-UHFFFAOYSA-N 625331 US20230322767, Example 159::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Casein kinase I isoform delta Homo sapiens 1.60 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625331&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687068 485207665 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333079 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccn1)c1ccc(F)cc1 InChI=1S/C30H24F3N5O2/c31-19-6-4-17(5-7-19)21(16-24(32)33)29(39)37-25-15-18(10-13-35-25)28-26(22-3-1-2-12-34-22)27-23(36-28)11-14-38(30(27)40)20-8-9-20/h1-7,10-15,20-21,24,36H,8-9,16H2,(H,35,37,39) SXZJJMQIEVMLRL-UHFFFAOYSA-N 625332 US20230322767, Example 160::(2RS)—N-{4-[5-cyclopropyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform alpha Homo sapiens 8.70 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625332&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687114 485207666 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333080 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccn1)c1ccc(F)cc1 InChI=1S/C30H24F3N5O2/c31-19-6-4-17(5-7-19)21(16-24(32)33)29(39)37-25-15-18(10-13-35-25)28-26(22-3-1-2-12-34-22)27-23(36-28)11-14-38(30(27)40)20-8-9-20/h1-7,10-15,20-21,24,36H,8-9,16H2,(H,35,37,39) SXZJJMQIEVMLRL-UHFFFAOYSA-N 625332 US20230322767, Example 160::(2RS)—N-{4-[5-cyclopropyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform delta Homo sapiens 10.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625332&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687114 485207666 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333081 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(Cl)cn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H23ClF4N4O2/c32-23-15-40(21-9-10-21)31(42)27-26(17-3-7-20(34)8-4-17)28(39-29(23)27)18-11-12-37-25(13-18)38-30(41)22(14-24(35)36)16-1-5-19(33)6-2-16/h1-8,11-13,15,21-22,24,39H,9-10,14H2,(H,37,38,41) WLUDGAUDVDKIOF-UHFFFAOYSA-N 625333 US20230322767, Example 161::(2RS)—N-{4-[7-chloro-5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform alpha Homo sapiens 20.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625333&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687079 485207667 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333082 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(Cl)cn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H23ClF4N4O2/c32-23-15-40(21-9-10-21)31(42)27-26(17-3-7-20(34)8-4-17)28(39-29(23)27)18-11-12-37-25(13-18)38-30(41)22(14-24(35)36)16-1-5-19(33)6-2-16/h1-8,11-13,15,21-22,24,39H,9-10,14H2,(H,37,38,41) WLUDGAUDVDKIOF-UHFFFAOYSA-N 625333 US20230322767, Example 161::(2RS)—N-{4-[7-chloro-5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Casein kinase I isoform delta Homo sapiens 11.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625333&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687079 485207667 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333083 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H23F6N5O2/c1-41-15-18(14-30(34,35)36)27-25(29(41)43)24(21-4-2-3-10-37-21)26(40-27)17-9-11-38-23(12-17)39-28(42)20(13-22(32)33)16-5-7-19(31)8-6-16/h2-12,15,20,22,40H,13-14H2,1H3,(H,38,39,42) LBQIACDBOWZJEM-UHFFFAOYSA-N 625334 US20230322767, Example 162::(2RS)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide Casein kinase I isoform alpha Homo sapiens 14.0 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625334&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 162687107 485207668 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333084 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H23F6N5O2/c1-41-15-18(14-30(34,35)36)27-25(29(41)43)24(21-4-2-3-10-37-21)26(40-27)17-9-11-38-23(12-17)39-28(42)20(13-22(32)33)16-5-7-19(31)8-6-16/h2-12,15,20,22,40H,13-14H2,1H3,(H,38,39,42) LBQIACDBOWZJEM-UHFFFAOYSA-N 625334 US20230322767, Example 162::(2RS)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide Casein kinase I isoform delta Homo sapiens 12.0 US Patent 10.7270/Q2DV1Q1G aid1919848 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7547&target=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625334&enzyme=Casein+kinase+I+isoform+delta&column=ki&startPg=0&Increment=50&submit=Search 162687107 485207668 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR 6PXN,4KBC,1CKJ,1CKI,5W4W,4KBK,4KBA,4KB8,4TN6,8VXF,8VXD,4JJR,7QRB,7QRA,7QR9,7P7H,7P7G,7P7F,6RU8,6RU7,6RU6,6RCH,6RCG,6PXO,5IH6,5IH5,5IH4,4HNF,4HGT,3UZP,3UYT,3UYS,8D7P,8D7O,8D7N,8D7M,7NZY,6HMR,6HMP,6F26,6F1W,5X17,5OKT,5MQV,8IZC Casein kinase I isoform delta KC1D_HUMAN P48730 A2I2P2 Q96KZ6 Q9BTN5 1333085 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H23FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-11,13,16,30H,12,14-15H2,1H3,(H,29,31,33) YQCOGLQBRIXLTH-UHFFFAOYSA-N 625175 US20230322767, Example 1::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625175 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625175&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687101 485207538 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333086 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333087 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Epidermal growth factor receptor Homo sapiens 108 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333088 CN1CCc2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H25F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-11,13,15,21,23,34H,12,14,16H2,1H3,(H,33,35,37) JBJCNSOGCYGMGW-UHFFFAOYSA-N 625176 4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 4::US20230322767, Example 3::US20230322767, Example 2 Epidermal growth factor receptor Homo sapiens 301 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625176 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625176&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686989 485207539 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333089 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H21FN4O2/c1-32-14-12-21-25(27(32)34)24(18-5-3-2-4-6-18)26(30-21)19-11-13-29-22(16-19)31-23(33)15-17-7-9-20(28)10-8-17/h2-14,16,30H,15H2,1H3,(H,29,31,33) FHPAOPMOHMSKCE-UHFFFAOYSA-N 625179 US20230322767, Example 5::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625179 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625179&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687228 485207540 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333090 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333091 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Epidermal growth factor receptor Homo sapiens 11800 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333092 Cn1ccc2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H23F3N4O2/c1-36-14-12-22-26(29(36)38)25(18-5-3-2-4-6-18)27(34-22)19-11-13-33-24(15-19)35-28(37)21(16-23(31)32)17-7-9-20(30)10-8-17/h2-15,21,23,34H,16H2,1H3,(H,33,35,37) GJLHWXHYCNHMFT-UHFFFAOYSA-N 625180 US20230322767, Example 8::US20230322767, Example 7::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate)::US20230322767, Example 6 Epidermal growth factor receptor Homo sapiens 7820 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625180 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625180&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687165 485207541 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333093 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333094 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333095 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H24F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-8,10-11,13,15,20,22,34H,9,12,14H2,1H3,(H,33,35,37) DPBBZVZOGCLXDJ-UHFFFAOYSA-N 625183 US20230322767, Example 10::US20230322767, Example 11::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 9 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625183&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687036 485207542 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333096 CN1CCc2[nH]c(c(c2C1=O)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H22FN5O2/c1-32-12-9-20-24(26(32)34)23(18-3-2-10-28-15-18)25(30-20)17-8-11-29-21(14-17)31-22(33)13-16-4-6-19(27)7-5-16/h2-8,10-11,14-15,30H,9,12-13H2,1H3,(H,29,31,33) LOTGQVOARVITHH-UHFFFAOYSA-N 625186 US20230322767, Example 12::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625186&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687126 485207543 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333097 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H26F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,17,21,37H,15-16H2,1-2H3,(H,35,36,39) TVWCCJYWNNRHHQ-UHFFFAOYSA-N 625187 US20230322767, Example 13::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625187 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625187&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686998 485207544 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333098 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625188 US20230322767, Example 14::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625188&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207545 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333099 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625189 US20230322767, Example 15::(+)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens 1910 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625189&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207546 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333100 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-17(18-8-10-22(31)11-9-18)28(39)36-23-14-20(12-13-35-23)26-24(19-6-4-3-5-7-19)25-27(37-26)21(15-30(32,33)34)16-38(2)29(25)40/h3-14,16-17,37H,15H2,1-2H3,(H,35,36,39) VTTNWVNGYMKTFA-UHFFFAOYSA-N 625190 US20230322767, Example 16::(-)-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625190&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687007 485207547 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333101 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,20,22-23,40H,14-16H2,1H3,(H,38,39,42) ZIJTUQQBFTXSRP-UHFFFAOYSA-N 625191 US20230322767, Example 17::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625191&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687110 485207548 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333102 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625192 US20230322767, Example 18::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625192&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207549 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333103 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625193 US20230322767, Example 19::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625193&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207550 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333104 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H24F6N4O2/c1-41-16-20(15-31(35,36)37)28-26(30(41)43)25(18-5-3-2-4-6-18)27(40-28)19-11-12-38-24(13-19)39-29(42)22(14-23(33)34)17-7-9-21(32)10-8-17/h2-13,16,22-23,40H,14-15H2,1H3,(H,38,39,42) TUSWCHQSBHMNQB-UHFFFAOYSA-N 625194 US20230322767, Example 20::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-phenyl-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625194&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687151 485207551 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333105 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC(F)(F)F)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H25F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,16,20,38H,14-15H2,1-2H3,(H,36,37,40) CVDSGACKMHURND-UHFFFAOYSA-N 625195 US20230322767, Example 21::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625195&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687163 485207552 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333106 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625196 US20230322767, Example 22::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625196&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207553 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333107 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625197 US20230322767, Example 23::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625197&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207554 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333108 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC(F)(F)F)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C30H23F5N4O2/c1-16(17-3-7-21(31)8-4-17)28(40)37-23-13-19(11-12-36-23)26-24(18-5-9-22(32)10-6-18)25-27(38-26)20(14-30(33,34)35)15-39(2)29(25)41/h3-13,15-16,38H,14H2,1-2H3,(H,36,37,40) UNQVLUNGEAHZPW-UHFFFAOYSA-N 625198 US20230322767, Example 24::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625198&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687072 485207555 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333109 CN1CC(CC(F)(F)F)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,19,22-23,41H,13-15H2,1H3,(H,39,40,43) YXAZIXFVTZLQCR-UHFFFAOYSA-N 625199 US20230322767, Example 25::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625199&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687193 485207556 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333110 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333111 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333112 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H23F7N4O2/c1-42-15-19(14-31(36,37)38)28-26(30(42)44)25(17-4-8-21(33)9-5-17)27(41-28)18-10-11-39-24(12-18)40-29(43)22(13-23(34)35)16-2-6-20(32)7-3-16/h2-12,15,22-23,41H,13-14H2,1H3,(H,39,40,43) ATJVIGPUJQKPPP-UHFFFAOYSA-N 625200 4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate)::US20230322767, Example 27::US20230322767, Example 28::US20230322767, Example 26 Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625200&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687119 485207557 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333113 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-14,16-17,34H,15H2,1-3H3,(H,32,33,36) JWORVNRMUHEHQU-UHFFFAOYSA-N 625203 US20230322767, Example 29::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625203&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687095 485207558 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333114 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625204 US20230322767, Example 30::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625204&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207559 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333115 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625205 US20230322767, Example 31::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625205&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207560 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333116 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H24F2N4O2/c1-16-15-35(3)29(37)25-24(19-6-10-22(31)11-7-19)27(34-26(16)25)20-12-13-32-23(14-20)33-28(36)17(2)18-4-8-21(30)9-5-18/h4-15,17,34H,1-3H3,(H,32,33,36) HZBBZBIWSKGLLH-UHFFFAOYSA-N 625206 US20230322767, Example 32::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625206&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686975 485207561 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333117 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H26F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,16,22-23,37H,14-15H2,1-2H3,(H,35,36,39) AFYHNCHUOWUSBR-UHFFFAOYSA-N 625207 US20230322767, Example 33::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625207&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687146 485207562 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333118 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625208 US20230322767, Example 34::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625208&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207563 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333119 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625209 US20230322767, Example 35::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625209&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207564 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333120 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccc(F)cc1 InChI=1S/C30H24F4N4O2/c1-16-15-38(2)30(40)26-25(18-5-9-21(32)10-6-18)28(37-27(16)26)19-11-12-35-24(13-19)36-29(39)22(14-23(33)34)17-3-7-20(31)8-4-17/h3-13,15,22-23,37H,14H2,1-2H3,(H,35,36,39) NIZDUIYCSULLSX-UHFFFAOYSA-N 625210 US20230322767, Example 36::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5,7-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625210&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687025 485207565 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333121 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(C)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-15,17-18,33H,16H2,1-3H3,(H,31,32,35) XXHPLAIMNDHJPS-UHFFFAOYSA-N 625211 US20230322767, Example 37::N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625211&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687083 485207566 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333122 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(C)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C29H25FN4O2/c1-17-16-34(3)29(36)25-24(20-7-5-4-6-8-20)27(33-26(17)25)21-13-14-31-23(15-21)32-28(35)18(2)19-9-11-22(30)12-10-19/h4-16,18,33H,1-3H3,(H,31,32,35) CUSGCSBOGPVLNM-UHFFFAOYSA-N 625212 US20230322767, Example 38::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625212&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687030 485207567 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333123 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333124 Cc1cn(C)c(=O)c2c(c([nH]c12)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1)-c1ccccc1 InChI=1S/C30H25F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,16,22-23,36H,15H2,1-2H3,(H,34,35,38) ATJMVWABXWLODR-UHFFFAOYSA-N 625214 US20230322767, Example 40::N-[4-(5,7-dimethyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625214&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687246 485207569 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333125 CC1CN(C)C(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-17-16-37(2)30(39)26-25(19-6-4-3-5-7-19)28(36-27(17)26)20-12-13-34-24(14-20)35-29(38)22(15-23(32)33)18-8-10-21(31)11-9-18/h3-14,17,22-23,36H,15-16H2,1-2H3,(H,34,35,38) SFEXHRDDQCDUFA-UHFFFAOYSA-N 625213 N-{4-[5,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers)::US20230322767, Example 41::US20230322767, Example 39 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625213&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687222 485207568 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333126 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-31-27(35)24-23(18-6-4-3-5-7-18)25(33-26(24)28)19-12-13-30-21(15-19)32-22(34)14-17-8-10-20(29)11-9-17/h3-13,15,33H,14,16H2,1-2H3,(H,31,35)(H,30,32,34) DZHGIWMUVYYVFJ-UHFFFAOYSA-N 625216 US20230322767, Example 42::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens 5600 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625216&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687118 485207570 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333127 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333128 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333129 CC1(C)CNC(=O)c2c1[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H27F3N4O2/c1-30(2)16-35-29(39)25-24(18-6-4-3-5-7-18)26(37-27(25)30)19-12-13-34-23(14-19)36-28(38)21(15-22(32)33)17-8-10-20(31)11-9-17/h3-14,21-22,37H,15-16H2,1-2H3,(H,35,39)(H,34,36,38) CUDDAPWFXFREAK-UHFFFAOYSA-N 625217 US20230322767, Example 45::US20230322767, Example 44::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 43 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625217&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687066 485207571 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333130 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333131 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333132 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(c1-c1ccccc1)C(=O)NCC2(C)C)c1ccc(F)cc1 InChI=1S/C29H27FN4O2/c1-17(18-9-11-21(30)12-10-18)27(35)33-22-15-20(13-14-31-22)25-23(19-7-5-4-6-8-19)24-26(34-25)29(2,3)16-32-28(24)36/h4-15,17,34H,16H2,1-3H3,(H,32,36)(H,31,33,35) LFHVHNSBFJSOBY-UHFFFAOYSA-N 625220 US20230322767, Example 47::US20230322767, Example 48::N-[4-(7,7-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 46 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625220&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687179 485207572 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333133 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625223 US20230322767, Example 49::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625223&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207573 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333134 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625224 US20230322767, Example 50::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens 11900 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625224&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207574 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333135 CN1C(=O)c2c(CC11CCC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C32H29F3N4O2/c1-39-31(41)28-24(18-32(39)13-5-14-32)37-29(27(28)20-6-3-2-4-7-20)21-12-15-36-26(16-21)38-30(40)23(17-25(34)35)19-8-10-22(33)11-9-19/h2-4,6-12,15-16,23,25,37H,5,13-14,17-18H2,1H3,(H,36,38,40) QWRVRFNSEGHCBL-UHFFFAOYSA-N 625225 US20230322767, Example 51::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens 3200 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625225&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687000 485207575 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333136 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625226 US20230322767, Example 52::2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625226&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207576 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333137 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625227 US20230322767, Example 53::(-)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625227&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207577 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333138 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC3(CCC3)N(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H29FN4O2/c1-19(20-9-11-23(32)12-10-20)29(37)35-25-17-22(13-16-33-25)28-26(21-7-4-3-5-8-21)27-24(34-28)18-31(14-6-15-31)36(2)30(27)38/h3-5,7-13,16-17,19,34H,6,14-15,18H2,1-2H3,(H,33,35,37) CDUQLOKKQHDIFD-UHFFFAOYSA-N 625228 US20230322767, Example 54::(+)-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro[cyclobutane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]propanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625228&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687157 485207578 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333139 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H29FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17,19,23,35H,7-8,15-16,18H2,1H3,(H,33,34,37) IYIPKVLXGPQOAG-UHFFFAOYSA-N 625229 US20230322767, Example 55::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Epidermal growth factor receptor Homo sapiens 3430 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625229&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687184 485207579 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333140 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H27FN4O2/c1-36-18-23(15-19-7-8-19)30-28(31(36)38)27(21-5-3-2-4-6-21)29(35-30)22-13-14-33-25(17-22)34-26(37)16-20-9-11-24(32)12-10-20/h2-6,9-14,17-19,35H,7-8,15-16H2,1H3,(H,33,34,37) HINDFIKMXAKSSM-UHFFFAOYSA-N 625230 US20230322767, Example 56::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625230&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687047 485207580 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333141 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H31FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17,19-20,24,36H,8-9,16,18H2,1-2H3,(H,34,35,38) UJTVNGWILMVGHV-UHFFFAOYSA-N 625231 US20230322767, Example 57::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625231&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687204 485207581 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333142 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C32H29FN4O2/c1-19(21-10-12-25(33)13-11-21)31(38)35-26-17-23(14-15-34-26)29-27(22-6-4-3-5-7-22)28-30(36-29)24(16-20-8-9-20)18-37(2)32(28)39/h3-7,10-15,17-20,36H,8-9,16H2,1-2H3,(H,34,35,38) WOJAWRJOQHZDRX-UHFFFAOYSA-N 625232 US20230322767, Example 58::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625232&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687160 485207582 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333143 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H31F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,19,23,25-26,39H,7-8,15,17-18H2,1H3,(H,37,38,41) CTPZTYYKWXJYMT-UHFFFAOYSA-N 625233 US20230322767, Example 59::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625233&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687043 485207583 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333144 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H29F3N4O2/c1-40-18-23(15-19-7-8-19)31-29(33(40)42)28(21-5-3-2-4-6-21)30(39-31)22-13-14-37-27(16-22)38-32(41)25(17-26(35)36)20-9-11-24(34)12-10-20/h2-6,9-14,16,18-19,25-26,39H,7-8,15,17H2,1H3,(H,37,38,41) ATBIVHXUOKHWSC-UHFFFAOYSA-N 625234 US20230322767, Example 60::N-{4-[7-(cyclopropylmethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625234&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687076 485207584 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333145 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C31H28F2N4O2/c1-37-17-22(14-18-2-3-18)30-28(31(37)39)27(20-6-10-24(33)11-7-20)29(36-30)21-12-13-34-25(16-21)35-26(38)15-19-4-8-23(32)9-5-19/h4-13,16,18,22,36H,2-3,14-15,17H2,1H3,(H,34,35,38) KLWJMSQFXDPWNW-UHFFFAOYSA-N 625235 US20230322767, Example 61::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide (Racemate) Epidermal growth factor receptor Homo sapiens 818 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625235&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687084 485207585 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333146 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2C(CC3CC3)CN(C)C(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H30F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16,18-19,23,37H,3-4,15,17H2,1-2H3,(H,35,36,39) QNOANZOPMMGGQK-UHFFFAOYSA-N 625236 US20230322767, Example 62::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625236&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687082 485207586 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333147 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(CC3CC3)cn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C32H28F2N4O2/c1-18(20-5-9-24(33)10-6-20)31(39)36-26-16-22(13-14-35-26)29-27(21-7-11-25(34)12-8-21)28-30(37-29)23(15-19-3-4-19)17-38(2)32(28)40/h5-14,16-19,37H,3-4,15H2,1-2H3,(H,35,36,39) GDPJYLRERIWTKI-UHFFFAOYSA-N 625237 US20230322767, Example 63::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625237&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686973 485207587 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333148 CN1CC(CC2CC2)c2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H30F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,18,22,25-26,40H,2-3,14,16-17H2,1H3,(H,38,39,42) BUTAQMUMZATNRF-UHFFFAOYSA-N 625238 US20230322767, Example 64::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (mixture of 4 stereoisomers) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625238&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687128 485207588 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333149 Cn1cc(CC2CC2)c2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C33H28F4N4O2/c1-41-17-22(14-18-2-3-18)31-29(33(41)43)28(20-6-10-24(35)11-7-20)30(40-31)21-12-13-38-27(15-21)39-32(42)25(16-26(36)37)19-4-8-23(34)9-5-19/h4-13,15,17-18,25-26,40H,2-3,14,16H2,1H3,(H,38,39,42) YWWLWBUGJCBTOP-UHFFFAOYSA-N 625239 US20230322767, Example 65::N-{4-[7-(cyclopropylmethyl)-3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625239&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687092 485207589 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333150 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333151 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333152 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1F)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-9.73,1.99,;-8.4,1.22,;-8.4,-.32,;-7.06,-1.09,;-5.73,-.32,;-4.26,-.8,;-3.36,.45,;-4.26,1.69,;-5.73,1.22,;-7.06,1.99,;-7.06,3.53,;-3.79,3.16,;-4.82,4.3,;-4.34,5.77,;-2.84,6.09,;-2.36,7.55,;-1.81,4.94,;-2.28,3.48,;-1.25,2.34,;-1.82,.45,;-1.05,1.78,;.49,1.78,;1.26,.45,;.49,-.88,;1.26,-2.22,;2.8,-2.22,;3.57,-.88,;3.57,-3.55,;2.8,-4.89,;3.57,-6.22,;2.8,-7.55,;5.11,-6.22,;5.11,-3.55,;5.88,-4.89,;7.42,-4.89,;8.19,-3.55,;9.73,-3.55,;7.42,-2.22,;5.88,-2.22,;-1.05,-.88,)| InChI=1S/C29H23F5N4O2/c1-38-11-9-22-26(29(38)40)25(19-7-6-18(31)13-21(19)32)27(36-22)16-8-10-35-24(12-16)37-28(39)20(14-23(33)34)15-2-4-17(30)5-3-15/h2-8,10,12-13,20,23,36H,9,11,14H2,1H3,(H,35,37,39) BLAQSCXKTBCBTO-UHFFFAOYSA-N 625240 US20230322767, Example 67::US20230322767, Example 68::N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 66 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625240&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687180 485207590 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333153 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333154 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333155 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccc(F)cc1F)c1ccc(F)cc1 |(2.8,-6.22,;3.57,-4.89,;2.8,-3.55,;3.57,-2.22,;1.26,-3.55,;.49,-2.22,;-1.05,-2.22,;-1.82,-.88,;-1.05,.45,;.49,.45,;1.26,-.88,;-3.36,-.88,;-4.26,-2.13,;-5.73,-1.65,;-7.06,-2.42,;-8.4,-1.65,;-8.4,-.11,;-9.73,.66,;-7.06,.66,;-7.06,2.2,;-5.73,-.11,;-4.26,.36,;-3.79,1.83,;-4.82,2.97,;-4.34,4.43,;-2.84,4.75,;-2.36,6.22,;-1.81,3.61,;-2.28,2.15,;-1.25,1,;5.11,-4.89,;5.88,-6.22,;7.42,-6.22,;8.19,-4.89,;9.73,-4.89,;7.42,-3.55,;5.88,-3.55,)| InChI=1S/C28H23F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-8-7-19(30)14-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-9,11,13-15,33H,10,12H2,1-2H3,(H,32,34,36) DMINLPAHFPZFFH-UHFFFAOYSA-N 625243 N-{4-[3-(2,4-difluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 70::US20230322767, Example 71::US20230322767, Example 69 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625243&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687177 485207591 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333156 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCNC(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H21FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-10,12,15,30H,11,13-14H2,(H,29,33)(H,28,31,32) SFMADGWHRCGBSQ-UHFFFAOYSA-N 625246 US20230322767, Example 72::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625246&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687104 485207592 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333157 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3cc[nH]c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C26H19FN4O2/c27-19-8-6-16(7-9-19)14-22(32)31-21-15-18(10-12-28-21)25-23(17-4-2-1-3-5-17)24-20(30-25)11-13-29-26(24)33/h1-13,15,30H,14H2,(H,29,33)(H,28,31,32) RTZRQMLMSQRVKR-UHFFFAOYSA-N 625247 US20230322767, Example 73::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625247&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422882 485207593 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333158 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2/c1-16(17-7-9-20(28)10-8-17)26(33)32-22-15-19(11-13-29-22)25-23(18-5-3-2-4-6-18)24-21(31-25)12-14-30-27(24)34/h2-11,13,15-16,31H,12,14H2,1H3,(H,30,34)(H,29,32,33) IQZPQUJCVSQAHV-UHFFFAOYSA-N 625248 US20230322767, Example 74::2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625248&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687206 485207594 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333159 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-10,12,14,20,22,34H,11,13,15H2,(H,33,37)(H,32,35,36) NWFHVGCAXUNSLN-UHFFFAOYSA-N 625249 US20230322767, Example 75::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625249&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687045 485207595 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333160 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2cc[nH]c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c29-19-8-6-16(7-9-19)20(15-22(30)31)27(36)35-23-14-18(10-12-32-23)26-24(17-4-2-1-3-5-17)25-21(34-26)11-13-33-28(25)37/h1-14,20,22,34H,15H2,(H,33,37)(H,32,35,36) GUSYZMMWQWPZSF-UHFFFAOYSA-N 625250 US20230322767, Example 76::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625250&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422883 485207596 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333161 Cn1cc(Cl)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H20ClFN4O2/c1-33-15-20(28)26-24(27(33)35)23(17-5-3-2-4-6-17)25(32-26)18-11-12-30-21(14-18)31-22(34)13-16-7-9-19(29)10-8-16/h2-12,14-15,32H,13H2,1H3,(H,30,31,34) MXKTVDFRBVSJHZ-UHFFFAOYSA-N 625251 US20230322767, Example 79::N-[4-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625251&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687026 485207597 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333162 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H27F3N4O2/c1-38-30(40)27-23(17-31(38)12-13-31)36-28(26(27)19-5-3-2-4-6-19)20-11-14-35-25(15-20)37-29(39)22(16-24(33)34)18-7-9-21(32)10-8-18/h2-11,14-15,22,24,36H,12-13,16-17H2,1H3,(H,35,37,39) KEZOOBHJFUUXAY-UHFFFAOYSA-N 625252 US20230322767, Example 80::4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5′-methyl-4′-oxo-3′-phenyl-1′,4′,5′,7′-tetrahydrospiro-[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl)pyridin-2-yl]butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625252&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687187 485207598 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333163 CN1C(=O)c2c(CC11CC1)[nH]c(c2-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H26F4N4O2/c1-39-30(41)27-23(16-31(39)11-12-31)37-28(26(27)18-4-8-21(33)9-5-18)19-10-13-36-25(14-19)38-29(40)22(15-24(34)35)17-2-6-20(32)7-3-17/h2-10,13-14,22,24,37H,11-12,15-16H2,1H3,(H,36,38,40) JIIUKZNINHUSRU-UHFFFAOYSA-N 625253 US20230322767, Example 81::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3′-(4-fluorophenyl)-5′-methyl-4′-oxo-1′,4′,5′,7′-tetrahydro-spiro[cyclopropane-1,6′-pyrrolo[3,2-c]pyridin]-2′-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625253&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687097 485207599 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333164 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H25FN4O2/c1-28(2)16-21-25(27(35)33-28)24(18-6-4-3-5-7-18)26(31-21)19-12-13-30-22(15-19)32-23(34)14-17-8-10-20(29)11-9-17/h3-13,15,31H,14,16H2,1-2H3,(H,33,35)(H,30,32,34) KUWRDHFUGZPJEA-UHFFFAOYSA-N 625254 US20230322767, Example 82::N-[4-(6,6-dimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625254&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687141 485207600 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333165 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-9-20(30)10-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-7-19(29)8-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) QLCNXGDPIFBNEO-UHFFFAOYSA-N 625255 US20230322767, Example 83::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625255&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687130 485207601 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333166 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccccc1F)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 |(-9.07,-2.26,;-8.3,-.92,;-9.83,-.51,;-6.96,-1.69,;-5.63,-.92,;-4.16,-1.4,;-3.26,-.15,;-4.16,1.09,;-5.63,.62,;-6.96,1.39,;-6.96,2.93,;-8.3,.62,;-3.69,2.56,;-4.72,3.7,;-4.24,5.17,;-2.74,5.49,;-1.71,4.34,;-2.18,2.88,;-1.15,1.73,;-1.72,-.15,;-.95,1.18,;.59,1.18,;1.36,-.15,;.59,-1.49,;1.36,-2.82,;2.9,-2.82,;3.67,-1.49,;3.67,-4.15,;5.21,-4.15,;5.98,-2.82,;7.52,-2.82,;8.29,-4.15,;9.83,-4.15,;7.52,-5.49,;5.98,-5.49,;-.95,-1.49,)| InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(19-5-3-4-6-20(19)30)26(32-21)17-11-12-31-22(14-17)33-23(35)13-16-7-9-18(29)10-8-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) XKQBNZMXBOTZTP-UHFFFAOYSA-N 625256 US20230322767, Example 84::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Epidermal growth factor receptor Homo sapiens 16000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625256&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687176 485207602 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333167 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccc(F)c1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24F2N4O2/c1-28(2)15-21-25(27(36)34-28)24(17-4-3-5-20(30)13-17)26(32-21)18-10-11-31-22(14-18)33-23(35)12-16-6-8-19(29)9-7-16/h3-11,13-14,32H,12,15H2,1-2H3,(H,34,36)(H,31,33,35) IANCPMFLRNSETO-UHFFFAOYSA-N 625257 US20230322767, Example 85::2-(4-fluorophenyl)-N-{4-[3-(3-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625257&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687048 485207603 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333168 Cc1cccc(c1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-5-4-6-19(13-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-11-12-31-23(15-20)33-24(35)14-18-7-9-21(30)10-8-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) VKLWOKCJHQIGOC-UHFFFAOYSA-N 625258 US20230322767, Example 86::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625258&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686988 485207604 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333169 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccccc1F)c1ccc(F)cc1 |(2.88,-5.51,;3.67,-4.13,;2.9,-2.8,;3.67,-1.47,;1.36,-2.8,;.59,-1.47,;-.95,-1.47,;-1.72,-.13,;-.95,1.2,;.59,1.2,;1.36,-.13,;-3.26,-.13,;-4.16,-1.38,;-5.63,-.9,;-6.96,-1.67,;-8.3,-.9,;-9.07,-2.24,;-9.83,-.49,;-8.3,.64,;-6.96,1.41,;-6.96,2.95,;-5.63,.64,;-4.16,1.11,;-3.69,2.58,;-4.72,3.72,;-4.24,5.19,;-2.74,5.51,;-1.71,4.36,;-2.18,2.9,;-1.15,1.75,;5.21,-4.13,;5.98,-2.8,;7.52,-2.8,;8.29,-4.13,;9.83,-4.13,;7.52,-5.47,;5.98,-5.47,)| InChI=1S/C29H26F2N4O2/c1-16(17-8-10-19(30)11-9-17)27(36)34-23-14-18(12-13-32-23)26-24(20-6-4-5-7-21(20)31)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) CESMQOAMBJTRME-UHFFFAOYSA-N 625259 US20230322767, Example 87::2-(4-fluorophenyl)-N-{4-[3-(2-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625259&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687062 485207605 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333170 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccc(C)c1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-6-5-7-20(14-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-12-13-32-24(15-21)34-28(36)18(2)19-8-10-22(31)11-9-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) DPXSVWSOUOLCJN-UHFFFAOYSA-N 625260 US20230322767, Example 88::N-{4-[6,6-dimethyl-3-(3-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625260&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687154 485207606 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333171 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(Cl)cc1)c1ccc(F)cc1 InChI=1S/C29H26ClFN4O2/c1-16(17-6-10-21(31)11-7-17)27(36)34-23-14-19(12-13-32-23)26-24(18-4-8-20(30)9-5-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NXZVSYWCPKVCRD-UHFFFAOYSA-N 625261 US20230322767, Example 89::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625261&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687199 485207607 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333172 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1ccc(Cl)cc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C28H24ClFN4O2/c1-28(2)15-21-25(27(36)34-28)24(17-5-7-19(29)8-6-17)26(32-21)18-11-12-31-22(14-18)33-23(35)13-16-3-9-20(30)10-4-16/h3-12,14,32H,13,15H2,1-2H3,(H,34,36)(H,31,33,35) CGUGCENQQQHEFN-UHFFFAOYSA-N 625262 US20230322767, Example 90::N-{4-[3-(4-chlorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625262&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687239 485207608 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333173 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(C)cc1)c1ccc(F)cc1 InChI=1S/C30H29FN4O2/c1-17-5-7-20(8-6-17)25-26-23(16-30(3,4)35-29(26)37)33-27(25)21-13-14-32-24(15-21)34-28(36)18(2)19-9-11-22(31)12-10-19/h5-15,18,33H,16H2,1-4H3,(H,35,37)(H,32,34,36) WXFWDDXWJIXSSH-UHFFFAOYSA-N 625263 US20230322767, Example 91::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625263&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687214 485207609 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333174 Cc1ccc(cc1)-c1c([nH]c2CC(C)(C)NC(=O)c12)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C29H27FN4O2/c1-17-4-8-19(9-5-17)25-26-22(16-29(2,3)34-28(26)36)32-27(25)20-12-13-31-23(15-20)33-24(35)14-18-6-10-21(30)11-7-18/h4-13,15,32H,14,16H2,1-3H3,(H,34,36)(H,31,33,35) QBGYCMODWQDKCX-UHFFFAOYSA-N 625264 US20230322767, Example 92::N-{4-[6,6-dimethyl-3-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625264&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686951 485207610 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333175 CC1(C)Cc2[nH]c(c(c2C(=O)N1)-c1cccnc1)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C27H24FN5O2/c1-27(2)14-20-24(26(35)33-27)23(18-4-3-10-29-15-18)25(31-20)17-9-11-30-21(13-17)32-22(34)12-16-5-7-19(28)8-6-16/h3-11,13,15,31H,12,14H2,1-2H3,(H,33,35)(H,30,32,34) UHKJLPKHZOTEFL-UHFFFAOYSA-N 625265 US20230322767, Example 93::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625265&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687029 485207611 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333176 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333177 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333178 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C29H26F2N4O2/c1-16(17-4-8-20(30)9-5-17)27(36)34-23-14-19(12-13-32-23)26-24(18-6-10-21(31)11-7-18)25-22(33-26)15-29(2,3)35-28(25)37/h4-14,16,33H,15H2,1-3H3,(H,35,37)(H,32,34,36) NCRIUOVTLDBYPL-UHFFFAOYSA-N 625266 2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate)::US20230322767, Example 96::US20230322767, Example 95::US20230322767, Example 94 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625266&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687100 485207612 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333179 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333180 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333181 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CC(C)(C)NC(=O)c2c1-c1cccnc1)c1ccc(F)cc1 InChI=1S/C28H26FN5O2/c1-16(17-6-8-20(29)9-7-17)26(35)33-22-13-18(10-12-31-22)25-23(19-5-4-11-30-15-19)24-21(32-25)14-28(2,3)34-27(24)36/h4-13,15-16,32H,14H2,1-3H3,(H,34,36)(H,31,33,35) XBQQDPWXSKKKQL-UHFFFAOYSA-N 625269 US20230322767, Example 98::US20230322767, Example 99::N-{4-[6,6-dimethyl-4-oxo-3-(pyridin-3-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate)::US20230322767, Example 97 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625269&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687061 485207613 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333182 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625272 US20230322767, Example 100::2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625272&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207614 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333183 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625273 US20230322767, Example 101::(-)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens 32.4 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625273 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625273&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207615 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333184 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C28H22F2N4O2/c1-16(17-3-7-20(29)8-4-17)27(35)33-23-15-19(11-13-31-23)26-24(18-5-9-21(30)10-6-18)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ACSUKGRGGMZYHI-UHFFFAOYSA-N 625274 US20230322767, Example 102::(+)-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens 875 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625274 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625274&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687004 485207616 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333185 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333186 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333187 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O2/c1-17(18-8-10-21(29)11-9-18)27(34)32-23-16-20(12-14-30-23)26-24(19-6-4-3-5-7-19)25-22(31-26)13-15-33(2)28(25)35/h3-17,31H,1-2H3,(H,30,32,34) OUQRCKNQVHENIF-UHFFFAOYSA-N 625275 US20230322767, Example 104::2-(4-fluorophenyl)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]propanamide (Racemate)::US20230322767, Example 105::US20230322767, Example 103 Epidermal growth factor receptor Homo sapiens 8220 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625275&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687225 485207617 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333188 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(Cl)c1)c1ccc(F)cc1 InChI=1S/C28H22ClFN4O2/c1-16(17-6-8-21(30)9-7-17)27(35)33-23-15-19(10-12-31-23)26-24(18-4-3-5-20(29)14-18)25-22(32-26)11-13-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) VBCYKNRNAQCIRZ-UHFFFAOYSA-N 625278 US20230322767, Example 106::N-{4-[3-(3-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625278&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687191 485207618 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333189 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625279 US20230322767, Example 107::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625279&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207619 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333190 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625280 US20230322767, Example 108::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens 663 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625280&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207620 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333191 Cn1ccc2[nH]c(c(-c3ccc(F)cc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H22F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-14,21,23,35H,15H2,1H3,(H,34,36,38) WBKHTUIWPNHAAL-UHFFFAOYSA-N 625281 US20230322767, Example 109::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens 3850 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625281&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687211 485207621 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333192 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1F)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C27H21F2N5O2/c1-15(16-5-7-18(28)8-6-16)26(35)33-21-14-17(9-12-30-21)24-22(19-4-3-11-31-25(19)29)23-20(32-24)10-13-34(2)27(23)36/h3-15,32H,1-2H3,(H,30,33,35) BKURPYZERHHSEV-UHFFFAOYSA-N 625282 US20230322767, Example 110::2-(4-fluorophenyl)-N-{4-[3-(2-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625282&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687135 485207622 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333193 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccnc1C)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H24FN5O2/c1-16(18-6-8-20(29)9-7-18)27(35)33-23-15-19(10-13-31-23)26-24(21-5-4-12-30-17(21)2)25-22(32-26)11-14-34(3)28(25)36/h4-16,32H,1-3H3,(H,31,33,35) SPSYPMSEFLCIIR-UHFFFAOYSA-N 625283 US20230322767, Example 111::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methylphenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625283&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 169285969 485207623 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333194 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1Cl)c1ccc(F)cc1 |(3.07,-5.52,;3.84,-4.19,;3.07,-2.85,;3.84,-1.52,;1.02,-2.85,;.27,-1.51,;-1.27,-1.51,;-2.04,-.18,;-1.27,1.16,;.27,1.16,;1.04,-.18,;-3.58,-.18,;-4.49,-1.42,;-5.95,-.95,;-7.28,-1.72,;-8.62,-.95,;-8.62,.59,;-10,1.28,;-7.28,1.36,;-7.28,2.9,;-5.95,.59,;-4.49,1.07,;-4.1,2.56,;-5.17,3.67,;-4.74,5.15,;-3.25,5.52,;-2.18,4.41,;-2.6,2.93,;-1.53,1.82,;5.38,-4.19,;6.15,-2.85,;7.69,-2.85,;8.46,-4.19,;10,-4.19,;7.69,-5.52,;6.15,-5.52,)| InChI=1S/C28H22ClFN4O2/c1-16(17-7-9-19(30)10-8-17)27(35)33-23-15-18(11-13-31-23)26-24(20-5-3-4-6-21(20)29)25-22(32-26)12-14-34(2)28(25)36/h3-16,32H,1-2H3,(H,31,33,35) ASSQRJJOLODGSX-UHFFFAOYSA-N 625284 US20230322767, Example 112::N-{4-[3-(2-chlorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625284&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687194 485207624 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333195 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccc(O)c1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-6-8-20(29)9-7-17)27(35)32-23-15-19(10-12-30-23)26-24(18-4-3-5-21(34)14-18)25-22(31-26)11-13-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) DCGFWGFEATUMQK-UHFFFAOYSA-N 625285 US20230322767, Example 113::2-(4-fluorophenyl)-N-{4-[3-(3-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625285&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686978 485207625 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333196 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-6-19(29)7-4-16)27(36)34-23-14-18(9-11-32-23)26-24(17-5-8-20(30)21(31)13-17)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) HWQQHGYFYYEJPD-UHFFFAOYSA-N 625286 US20230322767, Example 114::N-{4-[3-(3,4-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625286&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687022 485207626 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333197 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccoc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) KVANAHYNCXXVFJ-UHFFFAOYSA-N 625287 US20230322767, Example 115::2-(4-fluorophenyl)-N-{4-[3-(3-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625287&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687067 485207627 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333198 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccco1)c1ccc(F)cc1 InChI=1S/C26H21FN4O3/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) VACLTQRSBVUDMW-UHFFFAOYSA-N 625288 US20230322767, Example 116::2-(4-fluorophenyl)-N-{4-[3-(2-furyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625288&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687040 485207628 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333199 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)c(F)c(F)c1)c1ccc(F)cc1 InChI=1S/C28H20F4N4O2/c1-14(15-3-5-18(29)6-4-15)27(37)35-22-13-16(7-9-33-22)26-23(17-11-19(30)25(32)20(31)12-17)24-21(34-26)8-10-36(2)28(24)38/h3-14,34H,1-2H3,(H,33,35,37) CUOVQWSQXJWUPZ-UHFFFAOYSA-N 625289 US20230322767, Example 117::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3,4,5-trifluorophenyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625289&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687091 485207629 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333200 Cn1ccc2[nH]c(c(-c3cccnc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C28H22F3N5O2/c1-36-12-9-21-25(28(36)38)24(18-3-2-10-32-15-18)26(34-21)17-8-11-33-23(13-17)35-27(37)20(14-22(30)31)16-4-6-19(29)7-5-16/h2-13,15,20,22,34H,14H2,1H3,(H,33,35,37) WLAQANVUFCSRMA-UHFFFAOYSA-N 625290 US20230322767, Example 118::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-3-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625290&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686987 485207630 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333201 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(O)cc1)c1ccc(F)cc1 InChI=1S/C28H23FN4O3/c1-16(17-3-7-20(29)8-4-17)27(35)32-23-15-19(11-13-30-23)26-24(18-5-9-21(34)10-6-18)25-22(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) RKWUJVALCBMSHZ-UHFFFAOYSA-N 625291 US20230322767, Example 119::2-(4-fluorophenyl)-N-{4-[3-(4-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625291&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687217 485207631 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333202 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1F)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.38,2.6,;-1.29,1.51,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C28H21F3N4O2/c1-15(16-3-5-18(29)6-4-16)27(36)34-23-13-17(9-11-32-23)26-24(20-14-19(30)7-8-21(20)31)25-22(33-26)10-12-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) CKWPZOKUIUDWSA-UHFFFAOYSA-N 625292 US20230322767, Example 120::N-{4-[3-(2,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625292&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687142 485207632 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333203 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)cc(F)c1)c1ccc(F)cc1 InChI=1S/C28H21F3N4O2/c1-15(16-3-5-19(29)6-4-16)27(36)34-23-13-17(7-9-32-23)26-24(18-11-20(30)14-21(31)12-18)25-22(33-26)8-10-35(2)28(25)37/h3-15,33H,1-2H3,(H,32,34,36) VMRHBZTUDNJLEK-UHFFFAOYSA-N 625293 US20230322767, Example 121::N-{4-[3-(3,5-difluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625293&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687080 485207633 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333204 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(Cl)s1)c1ccc(F)cc1 InChI=1S/C26H20ClFN4O2S/c1-14(15-3-5-17(28)6-4-15)25(33)31-21-13-16(9-11-29-21)24-23(19-7-8-20(27)35-19)22-18(30-24)10-12-32(2)26(22)34/h3-14,30H,1-2H3,(H,29,31,33) LDHDORYQIJLGSC-UHFFFAOYSA-N 625294 US20230322767, Example 122::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >5710 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625294&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686979 485207634 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333205 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1C#N)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.34,2.91,;-.74,3.45,;.69,3.96,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C29H22FN5O2/c1-17(18-7-9-21(30)10-8-18)28(36)34-24-15-19(11-13-32-24)27-25(22-6-4-3-5-20(22)16-31)26-23(33-27)12-14-35(2)29(26)37/h3-15,17,33H,1-2H3,(H,32,34,36) QRVYIZSFRSIONY-UHFFFAOYSA-N 625295 US20230322767, Example 123::N-{4-[3-(2-cyanophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625295&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686955 485207635 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333206 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccccc1O)c1ccc(F)cc1 |(2.8,-5.52,;3.57,-4.19,;2.8,-2.85,;3.57,-1.52,;1.26,-2.85,;.49,-1.52,;-1.05,-1.52,;-1.82,-.19,;-1.05,1.15,;.49,1.15,;1.26,-.19,;-3.36,-.19,;-4.26,-1.43,;-5.73,-.96,;-7.06,-1.73,;-8.4,-.96,;-8.4,.58,;-9.73,1.35,;-7.06,1.35,;-7.06,2.89,;-5.73,.58,;-4.26,1.06,;-3.87,2.55,;-4.96,3.64,;-4.56,5.12,;-3.07,5.52,;-1.98,4.43,;-2.38,2.95,;-1.29,1.86,;5.11,-4.19,;5.88,-5.52,;7.42,-5.52,;8.19,-4.19,;9.73,-4.19,;7.42,-2.85,;5.88,-2.85,)| InChI=1S/C28H23FN4O3/c1-16(17-7-9-19(29)10-8-17)27(35)32-23-15-18(11-13-30-23)26-24(20-5-3-4-6-22(20)34)25-21(31-26)12-14-33(2)28(25)36/h3-16,31,34H,1-2H3,(H,30,32,35) UGZCBAQQMBKAOK-UHFFFAOYSA-N 625296 US20230322767, Example 124::2-(4-fluorophenyl)-N-{4-[3-(2-hydroxyphenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625296 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625296&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687124 485207636 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333207 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(C)s1)c1ccc(F)cc1 InChI=1S/C27H23FN4O2S/c1-15-4-9-21(35-15)24-23-20(11-13-32(3)27(23)34)30-25(24)18-10-12-29-22(14-18)31-26(33)16(2)17-5-7-19(28)8-6-17/h4-14,16,30H,1-3H3,(H,29,31,33) JIUXQQJKSDSLKZ-UHFFFAOYSA-N 625297 US20230322767, Example 125::2-(4-fluorophenyl)-N-{4-[5-methyl-3-(5-methyl-2-thienyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >1630 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625297&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687197 485207637 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333208 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccnc(N)c1)c1ccc(F)cc1 InChI=1S/C27H23FN6O2/c1-15(16-3-5-19(28)6-4-16)26(35)33-22-14-18(8-11-31-22)25-23(17-7-10-30-21(29)13-17)24-20(32-25)9-12-34(2)27(24)36/h3-15,32H,1-2H3,(H2,29,30)(H,31,33,35) PPUNDPQNOCBVKW-UHFFFAOYSA-N 625298 US20230322767, Example 126::N-{4-[3-(2-aminopyridin-4-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625298 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625298&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687010 485207638 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333209 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cc(F)ccc1C#N)c1ccc(F)cc1 |(2.8,-5.87,;3.57,-4.53,;2.8,-3.2,;3.57,-1.87,;1.26,-3.2,;.49,-1.87,;-1.05,-1.87,;-1.82,-.53,;-1.05,.8,;.49,.8,;1.26,-.53,;-3.36,-.53,;-4.26,-1.78,;-5.73,-1.3,;-7.06,-2.07,;-8.4,-1.3,;-8.4,.24,;-9.73,1.01,;-7.06,1.01,;-7.06,2.55,;-5.73,.24,;-4.26,.71,;-3.87,2.2,;-4.96,3.29,;-4.56,4.78,;-5.65,5.87,;-3.07,5.18,;-1.98,4.09,;-2.34,2.56,;-.92,1.64,;-.37,-.02,;5.11,-4.53,;5.88,-5.87,;7.42,-5.87,;8.19,-4.53,;9.73,-4.53,;7.42,-3.2,;5.88,-3.2,)| InChI=1S/C29H21F2N5O2/c1-16(17-3-6-20(30)7-4-17)28(37)35-24-13-18(9-11-33-24)27-25(22-14-21(31)8-5-19(22)15-32)26-23(34-27)10-12-36(2)29(26)38/h3-14,16,34H,1-2H3,(H,33,35,37) RYYNYPNIEUPDOA-UHFFFAOYSA-N 625299 US20230322767, Example 127::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625299&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687212 485207639 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333210 CN1CCc2[nH]c(c(c2C1=O)-c1cc(F)ccc1C#N)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 |(-7.42,3.68,;-6.09,2.91,;-6.09,1.37,;-4.75,.6,;-3.42,1.37,;-1.95,.89,;-1.05,2.14,;-1.95,3.38,;-3.42,2.91,;-4.75,3.68,;-4.75,5.22,;-1.56,4.87,;-2.65,5.96,;-2.25,7.45,;-3.34,8.53,;-.76,7.84,;.33,6.75,;-.03,5.23,;1.06,4.14,;2.15,3.05,;.49,2.14,;1.26,3.47,;2.8,3.47,;3.57,2.14,;2.8,.8,;3.57,-.53,;2.8,-1.87,;1.26,-1.87,;3.57,-3.2,;5.11,-3.2,;5.88,-4.53,;5.11,-5.87,;7.42,-4.53,;2.8,-4.53,;1.26,-4.53,;.49,-5.87,;1.26,-7.2,;.49,-8.53,;2.8,-7.2,;3.57,-5.87,;1.26,.8,)| InChI=1S/C30H23F4N5O2/c1-39-11-9-23-27(30(39)41)26(21-13-20(32)7-4-18(21)15-35)28(37-23)17-8-10-36-25(12-17)38-29(40)22(14-24(33)34)16-2-5-19(31)6-3-16/h2-8,10,12-13,22,24,37H,9,11,14H2,1H3,(H,36,38,40) UCWZHWFDHODGBP-UHFFFAOYSA-N 625300 US20230322767, Example 128::N-{4-[3-(2-cyano-5-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625300&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687078 485207640 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333211 CN1CCc2[nH]c(c(-c3cnc(C)s3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H24F3N5O2S/c1-14-32-13-20(38-14)24-23-19(8-10-35(2)27(23)37)33-25(24)16-7-9-31-22(11-16)34-26(36)18(12-21(29)30)15-3-5-17(28)6-4-15/h3-7,9,11,13,18,21,33H,8,10,12H2,1-2H3,(H,31,34,36) OPOQBSCRYUUEBT-UHFFFAOYSA-N 625301 US20230322767, Example 129::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-3-(2-methyl-1,3-thiazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625301&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687234 485207641 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333212 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1cccs1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-5-7-18(27)8-6-16)25(32)30-21-14-17(9-11-28-21)24-23(20-4-3-13-34-20)22-19(29-24)10-12-31(2)26(22)33/h3-15,29H,1-2H3,(H,28,30,32) NHWOIUQSMAGREQ-UHFFFAOYSA-N 625302 US20230322767, Example 130::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(2-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625302&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687175 485207642 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333213 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccsc1)c1ccc(F)cc1 InChI=1S/C26H21FN4O2S/c1-15(16-3-5-19(27)6-4-16)25(32)30-21-13-17(7-10-28-21)24-22(18-9-12-34-14-18)23-20(29-24)8-11-31(2)26(23)33/h3-15,29H,1-2H3,(H,28,30,32) GVIDEIQDBDMNLC-UHFFFAOYSA-N 625303 US20230322767, Example 131::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(3-thienyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625303&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687112 485207643 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333214 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1C)c1ccc(F)cc1 InChI=1S/C23H21FN4O2/c1-13(15-4-6-17(24)7-5-15)22(29)27-19-12-16(8-10-25-19)21-14(2)20-18(26-21)9-11-28(3)23(20)30/h4-13,26H,1-3H3,(H,25,27,29) XPNJMLZYFXKLLR-UHFFFAOYSA-N 625304 US20230322767, Example 132::N-[4-(3,5-dimethyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625304 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625304&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687244 485207644 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333215 Cn1ccc2[nH]c(c(-c3ccc(Cl)s3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C27H20ClF3N4O2S/c1-35-11-9-18-23(27(35)37)24(19-6-7-20(28)38-19)25(33-18)15-8-10-32-22(12-15)34-26(36)17(13-21(30)31)14-2-4-16(29)5-3-14/h2-12,17,21,33H,13H2,1H3,(H,32,34,36) RYHVMNZCJGRAGW-UHFFFAOYSA-N 625305 US20230322767, Example 133::N-{4-[3-(5-chloro-2-thienyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625305&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686965 485207645 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333216 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625306 US20230322767, Example 134::N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625306&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207646 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333217 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625307 US20230322767, Example 135::(-)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625307&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207647 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333218 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H24F4N4O2/c32-20-5-1-17(2-6-20)23(16-25(34)35)30(40)38-26-15-19(11-13-36-26)29-27(18-3-7-21(33)8-4-18)28-24(37-29)12-14-39(31(28)41)22-9-10-22/h1-8,11-15,22-23,25,37H,9-10,16H2,(H,36,38,40) UGFJLMYCKZVPQW-UHFFFAOYSA-N 625308 US20230322767, Example 136::(+)-N-{4-[5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625308 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625308&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687005 485207648 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333219 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333220 CN1CCc2[nH]c(c(-c3cscn3)c2C1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C26H22F3N5O2S/c1-34-9-7-18-23(26(34)36)22(19-12-37-13-31-19)24(32-18)15-6-8-30-21(10-15)33-25(35)17(11-20(28)29)14-2-4-16(27)5-3-14/h2-6,8,10,12-13,17,20,32H,7,9,11H2,1H3,(H,30,33,35) DAVLHGUDTGYPHJ-UHFFFAOYSA-N 625310 US20230322767, Example 138::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(1,3-thiazol-4-yl)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625310 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625310&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687127 485207650 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333221 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C29H24F4N4O2/c1-37-13-11-22-26(29(37)39)25(17-4-8-20(31)9-5-17)27(35-22)18-10-12-34-24(14-18)36-28(38)21(15-23(32)33)16-2-6-19(30)7-3-16/h2-10,12,14,21,23,35H,11,13,15H2,1H3,(H,34,36,38) HTDCNRIYLUVMQJ-UHFFFAOYSA-N 625311 US20230322767, Example 139::4,4-difluoro-2-(4-fluorophenyl)-N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625311&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686984 485207651 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333222 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H30FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-11,13,18,35H,12,14-17H2,1-2H3,(H,34,39)(H,33,36,38) HGJUNURCFJGYIC-UHFFFAOYSA-N 625312 US20230322767, Example 140::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625312 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625312&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687113 485207652 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333223 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3CCN(C)C(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H32FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-12,14,19,35H,13,15-18H2,1-3H3,(H,34,36,39) KURMGXLJUFMRKC-UHFFFAOYSA-N 625313 US20230322767, Example 141::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625313&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687052 485207653 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333224 COCCNC(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C31H28FN5O4/c1-37-15-12-24-28(31(37)40)27(20-7-9-23(32)10-8-20)29(35-24)22-11-13-33-25(18-22)36-26(38)17-19-3-5-21(6-4-19)30(39)34-14-16-41-2/h3-13,15,18,35H,14,16-17H2,1-2H3,(H,34,39)(H,33,36,38) URJGMIVEJKRPDY-UHFFFAOYSA-N 625314 US20230322767, Example 142::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)benzamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625314&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687055 485207654 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333225 COCCN(C)C(=O)c1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C)c(=O)c3c2-c2ccc(F)cc2)cc1 InChI=1S/C32H30FN5O4/c1-37-15-13-25-29(32(37)41)28(21-8-10-24(33)11-9-21)30(35-25)23-12-14-34-26(19-23)36-27(39)18-20-4-6-22(7-5-20)31(40)38(2)16-17-42-3/h4-15,19,35H,16-18H2,1-3H3,(H,34,36,39) IOTPYKAXEUJUIX-UHFFFAOYSA-N 625315 US20230322767, Example 143::4-[2-({4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}amino)-2-oxoethyl]-N-(2-methoxyethyl)-N-methylbenzamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625315&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687074 485207655 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333226 CN1CCc2[nH]c(c(c2C1=O)-c1ccc(F)cc1)-c1ccnc(NC(=O)Cc2ccc(cc2)C(=O)N2CCNCC2)c1 InChI=1S/C32H31FN6O3/c1-38-15-11-25-29(32(38)42)28(21-6-8-24(33)9-7-21)30(36-25)23-10-12-35-26(19-23)37-27(40)18-20-2-4-22(5-3-20)31(41)39-16-13-34-14-17-39/h2-10,12,19,34,36H,11,13-18H2,1H3,(H,35,37,40) FUBHPUWOZAXCKP-UHFFFAOYSA-N 625316 US20230322767, Example 144::N-{4-[3-(4-fluorophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-2-[4-(piperazine-1-carbonyl)phenyl]acetamide Epidermal growth factor receptor Homo sapiens 3620 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625316 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625316&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686970 485207656 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333227 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C)c(=O)c2c1-c1ccc(F)nc1)c1ccc(F)cc1 InChI=1S/C27H21F2N5O2/c1-15(16-3-6-19(28)7-4-16)26(35)33-22-13-17(9-11-30-22)25-23(18-5-8-21(29)31-14-18)24-20(32-25)10-12-34(2)27(24)36/h3-15,32H,1-2H3,(H,30,33,35) NXHUBNJAPUQPMR-UHFFFAOYSA-N 625317 US20230322767, Example 145::2-(4-fluorophenyl)-N-{4-[3-(6-fluoropyridin-3-yl)-5-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}propanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625317 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625317&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687015 485207657 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333228 Cn1ccc2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1 InChI=1S/C26H20FN5O2/c1-32-13-10-20-24(26(32)34)23(19-4-2-3-11-28-19)25(30-20)17-9-12-29-21(15-17)31-22(33)14-16-5-7-18(27)8-6-16/h2-13,15,30H,14H2,1H3,(H,29,31,33) OMNHTKCFSGFFKE-UHFFFAOYSA-N 625318 US20230322767, Example 146::2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625318&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687122 485207658 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333229 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333230 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Epidermal growth factor receptor Homo sapiens 8750 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333231 Cn1cc(CC(F)F)c2[nH]c(c(-c3ccccc3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H25F5N4O2/c1-40-16-20(13-23(33)34)29-27(31(40)42)26(18-5-3-2-4-6-18)28(39-29)19-11-12-37-25(14-19)38-30(41)22(15-24(35)36)17-7-9-21(32)10-8-17/h2-12,14,16,22-24,39H,13,15H2,1H3,(H,37,38,41) SILIXJIYAFGFLO-UHFFFAOYSA-N 625319 US20230322767, Example 148::(rac)-N-{4-[7-(2,2-difluoroethyl)-5-methyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 149::US20230322767, Example 147 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625319&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687017 485207659 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333232 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625322 US20230322767, Example 150::(rac)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-tri methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Racemate) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625322&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207660 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333233 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625323 US20230322767, Example 151::(-)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 1) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625323 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625323&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207661 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333234 CN1CC(C)(C)c2[nH]c(c(c2C1=O)-c1ccccc1)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C31H29F3N4O2/c1-31(2)17-38(3)30(40)26-25(19-7-5-4-6-8-19)27(37-28(26)31)20-13-14-35-24(15-20)36-29(39)22(16-23(33)34)18-9-11-21(32)12-10-18/h4-15,22-23,37H,16-17H2,1-3H3,(H,35,36,39) DIPYWXZZVYYRSW-UHFFFAOYSA-N 625324 US20230322767, Example 152::(+)-4,4-difluoro-2-(4-fluorophenyl)-N-[4-(5,7,7-trimethyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]butanamide (Enantiomer 2) Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625324&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687053 485207662 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333235 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333236 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333237 CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C)C(=O)c2c1-c1ccccc1)c1ccncc1 InChI=1S/C27H25N5O2/c1-17(18-8-12-28-13-9-18)26(33)31-22-16-20(10-14-29-22)25-23(19-6-4-3-5-7-19)24-21(30-25)11-15-32(2)27(24)34/h3-10,12-14,16-17,30H,11,15H2,1-2H3,(H,29,31,33) ZOVJNBZRGMYPLD-UHFFFAOYSA-N 625325 US20230322767, Example 155::US20230322767, Example 154::(Rac)-N-[4-(5-methyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(pyridin-4-yl)propanamide (Racemate)::US20230322767, Example 153 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625325&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687105 485207663 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333238 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2CCN(C3CC3)C(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H27F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12,14,16,22-23,25,36H,10-11,13,15,17H2,(H,35,37,39) JVIJLVJHTLMUII-UHFFFAOYSA-N 625328 US20230322767, Example 156::(2RS)—N-(4-(5-cyclopropyl-4-oxo-3-phenyl-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl)-4,4-difluoro-2-(4-fluorophenyl)butanamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625328&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162686952 485207664 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333239 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333240 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccc1)c1ccc(F)cc1 InChI=1S/C31H25F3N4O2/c32-21-8-6-18(7-9-21)23(17-25(33)34)30(39)37-26-16-20(12-14-35-26)29-27(19-4-2-1-3-5-19)28-24(36-29)13-15-38(31(28)40)22-10-11-22/h1-9,12-16,22-23,25,36H,10-11,17H2,(H,35,37,39) PYMWZDTYIUIOGG-UHFFFAOYSA-N 625309 US20230322767, Example 158::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-4,4-difluoro-2-(4-fluorophenyl)butanamide (Racemate)::US20230322767, Example 157::US20230322767, Example 137 Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625309 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625309&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687231 485207649 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333241 Fc1ccc(CC(=O)Nc2cc(ccn2)-c2[nH]c3ccn(C4CC4)c(=O)c3c2-c2ccccc2)cc1 InChI=1S/C29H23FN4O2/c30-21-8-6-18(7-9-21)16-25(35)33-24-17-20(12-14-31-24)28-26(19-4-2-1-3-5-19)27-23(32-28)13-15-34(29(27)36)22-10-11-22/h1-9,12-15,17,22,32H,10-11,16H2,(H,31,33,35) YDSYMWHEHOEDFK-UHFFFAOYSA-N 625331 US20230322767, Example 159::N-[4-(5-cyclopropyl-4-oxo-3-phenyl-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl)pyridin-2-yl]-2-(4-fluorophenyl)acetamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625331&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687068 485207665 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333242 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2ccn(C3CC3)c(=O)c2c1-c1ccccn1)c1ccc(F)cc1 InChI=1S/C30H24F3N5O2/c31-19-6-4-17(5-7-19)21(16-24(32)33)29(39)37-25-15-18(10-13-35-25)28-26(22-3-1-2-12-34-22)27-23(36-28)11-14-38(30(27)40)20-8-9-20/h1-7,10-15,20-21,24,36H,8-9,16H2,(H,35,37,39) SXZJJMQIEVMLRL-UHFFFAOYSA-N 625332 US20230322767, Example 160::(2RS)—N-{4-[5-cyclopropyl-4-oxo-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625332&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687114 485207666 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333243 FC(F)CC(C(=O)Nc1cc(ccn1)-c1[nH]c2c(Cl)cn(C3CC3)c(=O)c2c1-c1ccc(F)cc1)c1ccc(F)cc1 InChI=1S/C31H23ClF4N4O2/c32-23-15-40(21-9-10-21)31(42)27-26(17-3-7-20(34)8-4-17)28(39-29(23)27)18-11-12-37-25(13-18)38-30(41)22(14-24(35)36)16-1-5-19(33)6-2-16/h1-8,11-13,15,21-22,24,39H,9-10,14H2,(H,37,38,41) WLUDGAUDVDKIOF-UHFFFAOYSA-N 625333 US20230322767, Example 161::(2RS)—N-{4-[7-chloro-5-cyclopropyl-3-(4-fluorophenyl)-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}-4,4-difluoro-2-(4-fluorophenyl)butanamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625333&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687079 485207667 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333244 Cn1cc(CC(F)(F)F)c2[nH]c(c(-c3ccccn3)c2c1=O)-c1ccnc(NC(=O)C(CC(F)F)c2ccc(F)cc2)c1 InChI=1S/C30H23F6N5O2/c1-41-15-18(14-30(34,35)36)27-25(29(41)43)24(21-4-2-3-10-37-21)26(40-27)17-9-11-38-23(12-17)39-28(42)20(13-22(32)33)16-5-7-19(31)8-6-16/h2-12,15,20,22,40H,13-14H2,1H3,(H,38,39,42) LBQIACDBOWZJEM-UHFFFAOYSA-N 625334 US20230322767, Example 162::(2RS)-4,4-difluoro-2-(4-fluorophenyl)-N-{4-[5-methyl-4-oxo-3-(pyridin-2-yl)-7-(2,2,2-trifluoroethyl)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}butanamide Epidermal growth factor receptor Homo sapiens >20000 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625334&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 162687107 485207668 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333245 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N5O2/c1-12(26)23-16-11-13(7-9-21-16)18-19(24-14-5-3-2-4-6-14)17-15(25-18)8-10-22-20(17)27/h2-7,9,11,24-25H,8,10H2,1H3,(H,22,27)(H,21,23,26) OEXTZXWPZXNIIH-UHFFFAOYSA-N 415414 US10428063, Example 14::Example 14 (N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::WO 2016/120196, Example 14::US20230322767, Example No. 14 WO 2016/120196::US20230339939, WO 2016/120196, Example 14::WO2016/120196, Example 14 Casein kinase I isoform alpha Homo sapiens 20.3 US Patent 10.7270/Q2DV1Q1G aid1919850 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415414&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442118 433915451 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333246 CC(=O)Nc1cc(ccn1)-c1[nH]c2CCNC(=O)c2c1Nc1ccccc1 InChI=1S/C20H19N5O2/c1-12(26)23-16-11-13(7-9-21-16)18-19(24-14-5-3-2-4-6-14)17-15(25-18)8-10-22-20(17)27/h2-7,9,11,24-25H,8,10H2,1H3,(H,22,27)(H,21,23,26) OEXTZXWPZXNIIH-UHFFFAOYSA-N 415414 US10428063, Example 14::Example 14 (N-{4-[4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide)::WO 2016/120196, Example 14::US20230322767, Example No. 14 WO 2016/120196::US20230339939, WO 2016/120196, Example 14::WO2016/120196, Example 14 Epidermal growth factor receptor Homo sapiens 104 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415414&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 122442118 433915451 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333247 Fc1cnccc1-c1[nH]c2cc[nH]c(=O)c2c1Nc1ccccc1 InChI=1S/C18H13FN4O/c19-13-10-20-8-6-12(13)16-17(22-11-4-2-1-3-5-11)15-14(23-16)7-9-21-18(15)24/h1-10,22-23H,(H,21,24) OWZSUHGYHPDMLH-UHFFFAOYSA-N 625336 US20230322767, Example No. 16 WO 2016/120196::WO 2016/120196, Example 16::2-(3-fluoropyridin-4-yl)-3-(phenylamino)-1 ,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one Casein kinase I isoform alpha Homo sapiens 40.3 US Patent 10.7270/Q2DV1Q1G aid1919850 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625336&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 169422884 485207670 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333248 Fc1cnccc1-c1[nH]c2cc[nH]c(=O)c2c1Nc1ccccc1 InChI=1S/C18H13FN4O/c19-13-10-20-8-6-12(13)16-17(22-11-4-2-1-3-5-11)15-14(23-16)7-9-21-18(15)24/h1-10,22-23H,(H,21,24) OWZSUHGYHPDMLH-UHFFFAOYSA-N 625336 US20230322767, Example No. 16 WO 2016/120196::WO 2016/120196, Example 16::2-(3-fluoropyridin-4-yl)-3-(phenylamino)-1 ,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one Epidermal growth factor receptor Homo sapiens 303 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625336&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 169422884 485207670 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333249 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(C)=O)c1 InChI=1S/C21H21N5O2/c1-13(27)23-17-12-14(8-10-22-17)19-20(24-15-6-4-3-5-7-15)18-16(25-19)9-11-26(2)21(18)28/h3-8,10,12,24-25H,9,11H2,1-2H3,(H,22,23,27) LPYBJNPKBPALQQ-UHFFFAOYSA-N 415423 US10428063, Example 23::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide::WO 2016/120196, Example 23::US20230322767, Example No. 23 WO 2016/120196::US20230339939, WO 2016/120196, Example 23::WO2016/120196, Example 23 Casein kinase I isoform alpha Homo sapiens 11.4 US Patent 10.7270/Q2DV1Q1G aid1919847 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415423&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122452966 433915460 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333250 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(C)=O)c1 InChI=1S/C21H21N5O2/c1-13(27)23-17-12-14(8-10-22-17)19-20(24-15-6-4-3-5-7-15)18-16(25-19)9-11-26(2)21(18)28/h3-8,10,12,24-25H,9,11H2,1-2H3,(H,22,23,27) LPYBJNPKBPALQQ-UHFFFAOYSA-N 415423 US10428063, Example 23::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide::WO 2016/120196, Example 23::US20230322767, Example No. 23 WO 2016/120196::US20230339939, WO 2016/120196, Example 23::WO2016/120196, Example 23 Epidermal growth factor receptor Homo sapiens 150 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415423&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 122452966 433915460 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333251 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 US10428063, Example 24::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 24::US20230322767, Example No. 24 WO 2016/120196::US20230339939, WO 2016/120196, Example 24::WO2016/120196, Example 24 Casein kinase I isoform alpha Homo sapiens <3.43 US Patent 10.7270/Q2DV1Q1G aid1919850 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333252 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)C2CC2)c1 InChI=1S/C23H23N5O2/c1-28-12-10-17-19(23(28)30)21(25-16-5-3-2-4-6-16)20(26-17)15-9-11-24-18(13-15)27-22(29)14-7-8-14/h2-6,9,11,13-14,25-26H,7-8,10,12H2,1H3,(H,24,27,29) CAOVBAQHBWKZJG-UHFFFAOYSA-N 415424 US10428063, Example 24::N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 24::US20230322767, Example No. 24 WO 2016/120196::US20230339939, WO 2016/120196, Example 24::WO2016/120196, Example 24 Epidermal growth factor receptor Homo sapiens 42.6 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415424&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 122442100 433915461 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333253 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 |r| InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 625339 US20230322767, Example No. 25 WO 2016/120196::US20230339939, WO 2016/120196, Example 25::rel-(1 R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1 H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 25 Casein kinase I isoform alpha Homo sapiens 62.5 US Patent 10.7270/Q2DV1Q1G aid1919850 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625339&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442136 485207673 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333254 CN1CCc2[nH]c(c(Nc3ccccc3)c2C1=O)-c1ccnc(NC(=O)[C@H]2C[C@H]2F)c1 |r| InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 625339 US20230322767, Example No. 25 WO 2016/120196::US20230339939, WO 2016/120196, Example 25::rel-(1 R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1 H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO2016/120196, Example 25 Epidermal growth factor receptor Homo sapiens 321 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=625339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=625339&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 122442136 485207673 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5 1333255 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@H]1C[C@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415425 US10428063, Example 25::US10428063, Example 40::rel-(1R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 40::US20230322767, Example No. 40 WO 2016/120196::US20230339939, WO 2016/120196, Example 40 Casein kinase I isoform alpha Homo sapiens 24.1 US Patent 10.7270/Q2DV1Q1G aid1919850 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2750&target=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415425&enzyme=Casein+kinase+I+isoform+alpha&column=ki&startPg=0&Increment=50&submit=Search 122442136 433915462 1 MASSSGSKAEFIVGGKYKLVRKIGSGSFGDIYLAINITNGEEVAVKLESQKARHPQLLYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF 8G66,5FQD,9OTY Casein kinase I isoform alpha KC1A_HUMAN P48729 D3DQG0 D3DQG1 Q4JJA0 Q5U046 Q5U047 Q6FGA2 Q71TU5 Q96HD2 Q9UDK3 1333256 CN5CCc4[nH]c(c2ccnc(NC(=O)[C@H]1C[C@H]1F)c2)c(Nc3ccccc3)c4C5=O InChI=1S/C23H22FN5O2/c1-29-10-8-17-19(23(29)31)21(26-14-5-3-2-4-6-14)20(27-17)13-7-9-25-18(11-13)28-22(30)15-12-16(15)24/h2-7,9,11,15-16,26-27H,8,10,12H2,1H3,(H,25,28,30) BSAVGANXIAKUQK-UHFFFAOYSA-N 415425 US10428063, Example 25::US10428063, Example 40::rel-(1R,2R)-2-fluoro-N-{4-[5-methyl-4-oxo-3-(phenylamino)-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}cyclopropanecarboxamide::WO 2016/120196, Example 40::US20230322767, Example No. 40 WO 2016/120196::US20230339939, WO 2016/120196, Example 40 Epidermal growth factor receptor Homo sapiens 85.5 US Patent 10.7270/Q2DV1Q1G aid1919849 US20230322767 Schulze, V; Mengel, A; Faria Alvares De Lemos, AC; Rauh, U; Bomer, U; Hillig, R; Lechner, C; Mortier, JX; Kaulfuss, S; Corsello, S; Handing, K; Madec, A; Furst, L; Shekhar, M; McKinney, D 10/12/2023 11/22/2023 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=415425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=520&target=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=415425&enzyme=Epidermal+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 122442136 433915462 1 MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA 3QWQ,1IVO,4UV7,9IPE,9IPD,9IPC,9IPB,9IPA,9IP9,9IP8,9IP7,4KRO,3B2V,4KRP,4UIP,1MOX,5WB8,5WB7,3GOP,8UKV,9P9U,7AEM,7SI1,7B85,5EM8,5CAV,1M17,1M14,4TKS,7UKV,3VJO,8PNZ,7AEI,5UGB,4I23,1XKK,9QXN,9Q0S,9PMZ,9OU9,9OS6,9NM0,9NJN,9NJ7,9NIS,9NHW,9NGP,9MST,9MSS,9MSR,9KL4,9H47,9H46,9H42,9GL9,9GI9,9FRD,9DM8,8SC7,8G63,6VHP,6VHN,6VH4,6D8E,4ZAU,4WRG,4WKQ,4G5J,3W33,3W32,3W2S,3POZ,2RF9,2J6M,2J5F,2J5E,2ITY,2ITX,2ITW,2GS6,2GS2,7T4I,5FED,9FZS,9FZR,9BY6,9BY4,6JZ0,4JRV,4JR3,4JQ8,4JQ7,8PO0,4LI5,9U8C Epidermal growth factor receptor EGFR_HUMAN P00533 O00688 O00732 P06268 Q14225 Q68GS5 Q92795 Q9BZS2 Q9GZX1 Q9H2C9 Q9H3C9 Q9UMD7 Q9UMD8 Q9UMG5